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Abstract 
 
Aminoacyl-tRNA synthetases (aaRSs) are ancient enzymes that charge tRNA with its 
cognate amino acid.  In order to maintain fidelity during protein synthesis, editing mechanisms 
ensure that tRNAs are accurately charged.  Leucyl-tRNA synthetase (LeuRS) has an editing 
active site that resides in a discrete domain called the connective polypeptide 1 domain (CP1). 
Post-transfer editing involves the translocation of mischarged tRNA from the aminoacylation to 
the editing active site where mischarged tRNA binds for hydrolysis of the noncognate amino 
acid to enhance fidelity.  Based on crystal structure analysis, the CP1 domain rotates 30° 
relative to the canonical core where aminoacylation occurs during tRNA translocation and 
presumably facilitates the movement of tRNA from the core domain to the editing domain.  
Single molecule fluorescence resonance energy transfer (smFRET) techniques were employed 
to characterize this dynamic movement of tRNA from one domain of the enzyme to another.  
Human cytoplasmic LeuRS (hscLeuRS) is typically found in a macromolecular complex 
containing at least eight other proteins.  In order to study this enzyme, hscLeuRS was expressed 
independent of the complex in Escherichia coli.  Enzymatic characterization of the isolated 
hscLeuRS suggested that it attaches a second leucine to Leu-tRNALeu.  Liquid chromatography 
and mass spectrometry methods were used in an attempt to isolate this hypothesized “doubly 
charged” tRNA species and it is possible that hscLeuRS possesses a secondary function beyond 
aminoacylation reliant on a doubly charged Leu-Leu-tRNALeu.  Further biochemical analysis of 
the hscLeuRS focused on its editing pocket.  The editing site of hscLeuRS includes a highly 
conserved threonine discriminator and universally conserved aspartic acid that were 
mutationally characterized.  Substitution of threonine to alanine uncoupled specificity similar to 
other LeuRSs.  However, the introduction of bulky residues in the amino acid binding pocket 
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failed to block deacylation of tRNA, indicating that the architecture of the amino acid binding 
pocket is different compared to other characterized LeuRSs.  In addition, mutation of the 
universally conserved aspartic acid abolished tRNALeu deacylation.  Surprisingly though, this 
editing-defective hscLeuRS maintained fidelity.  This indicates that an alternate editing 
mechanism may have been activated upon failure of the post-transfer editing active site in order 
to maintain fidelity during protein synthesis.  
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Chapter I: Introduction 
 
I.1. General Features of Aminoacyl-tRNA Synthetases 
 
 Accurate protein synthesis is dependent upon a group of ancient enzymes: Aminoacyl-
tRNA synthetases (aaRSs).  Typically, each aaRS is responsible for activating one of the twenty 
standard amino acids, which provide diversity in protein structure that is important for protein 
function.  Identity elements within the tRNAs serve as molecular determinants that confer 
specificity of the aaRS for tRNA (Giegé et al. 1998).  This ensures precise interaction between 
the tRNA and synthetase, thus promoting accurate protein synthesis.  
The aaRSs are divided into two classes based on their chemical properties, architecture 
of their catalytic domains as well as the presence of certain consensus sequences               
(Cusack et al. 1990; Eriani et al. 1990; Ribas de Pouplana and Schimmel 2001).  Each class is 
then further separated into three subclasses a, b, and c based on their unique mechanistic 
properties, anticodon-binding domain characteristics as well as the organization of structural 
motifs unique to each of the two main classes (Table 1.1) (Moras 1992; Cusack 1995;       
Landes et al. 1995; Ribas de Pouplana and Schimmel 2001; Mascarenhas et al. 2008).  A 
Rossmann dinucleotide binding fold defines the core of class I aaRSs that is also marked by two 
unique sequences, “KMSKS” (Lys-Met-Ser-Lys-Ser) (Hountondji et al. 1986) and “HIGH”                
(His-Ile-Gly-His) (Webster et al. 1984).  The HIGH sequence plays a role in amino acid 
activation (Webster et al. 1984), while the KMSKS sequence stabilizes the 3’ end of tRNA and 
allows amino acid to be charged to it (Fersht et al. 1988; Perona et al. 1993;                         
Arnez and Moras 1997).  
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Table I.1.  Classification of aaRSs based on structural    
and chemical properties 
Class I Class II 
Ia IIa 
LeuRS* SerRS 
IleRS* ThrRS* 
ValRS* AlaRS* 
MetRS* GlyRS* 
CysRS ProRS* 
ArgRS HisRS 
    
Ib IIb 
GlnRS AspRS 
GluRS AsnRS 
LysRS-I LysRS-II* 
    
Ic IIc 
TyrRS PheRS* 
TrpRS   
  SepRS 
  PylRS 
*These amino acids have a hydrolytic editing pathway to 
clear misactivated and mischarged amino acids 
 
In contrast, class II aaRSs are usually found in dimeric or tetrameric form and possess a 
catalytic core that is comprised of seven antiparallel β-strands flanked by α-helices       
(Rossmann et al. 1974; Rould et al. 1989; Cusack et al. 1990).  The canonical active site also 
harbors three conserved motifs.  Motif 1 [gφxxφxxpφφ] is found at the interface of the dimer 
while motif 2 [fRxe-h/rxxxFxxx(d/e)] and motif 3 [gφgφgφ(d/e)Rφφφφφ] comprise part of the 
aminoacylation active site (φ represents a hydrophobic amino acid) (Cusack et al. 1990;       
Eriani et al. 1990; Ruff et al. 1991) (Figure I.1).  Of note, in the past decade two new aaRSs that 
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activate O-phosphoserine and pyrrolysine have been added to the class II group           
(Polycarpo et al. 2004; Sethi et al. 2005). 
Lysyl-tRNA synthetase (LysRS) has been historically associated with the class II aaRSs, 
but is unique because a few examples from archaea have been found to be represented in class I 
too (Ibba et al. 1997).  Methanococcus maripaludis LysRS for example is a 62 kilodalton 
protein that resembles a class I synthetase, in contrast to other known examples of class II 
LysRSs that are bacterial and eukaryotic in origin (Ibba et al. 1997).  Generally, class I and II 
LysRSs do not co-exist in organisms, with the exception of Methanosarcineae, where both the 
LysRSs are thought to be involved in the translation of pyrrolysine (Galagan et al. 2002;        
Ibba and Söll 2002; Polycarpo et al. 2003).  
 
Figure I.1 Conserved sequences in class I and II aaRS active sites.  The LeuRS enzyme from 
Thermus thermophilus (T. thermophilus) is shown on the left with a sulphamoyl analogue of 
leucyl-adenylate drawn in black within the synthetic active site. The conserved sequences 
HMGH and MSKSK are highlighted (PDB: 2VOC) (Rock et al. 2007).  Glycyl-tRNA 
synthetase (GlyRS) is shown on the right with ATP drawn in black in the active site.  The three 
conserved motifs characteristic of class II aaRSs are highlighted.  Motif 1 is colored in orange, 
motif 2 in purple and motif 3 in blue. ATP is shown in black. (PDB: 1B76) (Arnez et al. 1999). 
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Some aaRSs have evolved to acquire insertions in addition to their catalytic canonical 
core.  In many cases, these inserted domains enhance the enzyme’s specificity and fidelity for 
the aminoacylation reaction (Schimmel and Ribas De Pouplana 2000).  One example of this is 
the connective polypeptide 1 (CP1) hydrolytic editing domain (Starzyk et al. 1987;                 
Lin et al. 1996) that is possessed by some aaRSs to maintain fidelity during the charging of 
tRNA with cognate amino acid.  Another example of an inserted domain present in some aaRSs 
is the C-terminal anticodon binding domain (ABD).  The ABD is essential for anticodon loop 
recognition of most aaRSs with the exception of leucyl-tRNA synthetase (LeuRS), seryl-tRNA 
synthetase (SerRS), and alanyl-tRNA synthetase (AlaRS) (Asahara et al. 1993;                
Asahara et al. 1993; Giegé et al. 1998).  These ABDs are highly varied in their structure. For 
example, ABDs from glutamyl-tRNA synthetase (GluRS) (Nureki et al. 1995) and glutaminyl-
tRNA synthetase (GlnRS) (Rould et al. 1989) are primarily made up of α-helices and β-strands, 
respectively. 
I.2. Mechanism of Aminoacylation Reaction 
During protein synthesis, aaRSs ensure that amino acid is charged to the 3’ end of its 
cognate tRNA with an error rate of less than 1 in 104 (Loftfield 1963).  This charged tRNA is 
then bound by elongation factor Tu (EF-Tu) and transported to the ribosome for protein 
synthesis.  Maintenance of fidelity during translation is crucial as mistakes can result in 
deceased viability of cells and disease (Karkhanis et al. 2006; Lee et al. 2006).   
The aaRSs catalyze a two-step reaction mechanism.  In the first step, amino acid is 
activated with ATP by the aaRS to form an aminoacyl-adenylate intermediate with the release 
of pyrophosphate (PPi).  In the second step, this activated amino acid then gets charged to the 3’ 
end of its cognate tRNA (Ibba and Söll 2004; Mascarenhas et al. 2008). 
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                                   ATP + Amino Acid (AA)  AA-AMP + PPi                                (I.1) 
 
                                   AA-AMP + tRNAAA        → AA-tRNAAA + AMP                        (I.2) 
 
 
Both classes of aaRSs catalyze the two-step aminoacylation reaction via different 
mechanisms.  Class I aaRSs bind ATP in an extended conformation (Brick and Blow 1987; 
Fersht et al. 1988), while class II aaRSs bind ATP in a bent conformation (Rould et al. 1989; 
Cavarelli et al. 1994).  In addition, the class I aaRSs bind the tRNA stem via the minor groove 
side (Rould et al. 1989), thus orienting the 2’-hydroxyl group of the A76 ribose for attachment 
of amino acid (Sprinzl and Cramer 1975).  In contrast, class II aaRSs bind ATP in a bent 
conformation (Rould et al. 1989; Cavarelli et al. 1994) and bind the tRNA stem via the major 
groove side (Ruff et al. 1991), resulting in the 3’-hydroxyl group being more accessible for 
charging (Figure I.2) (Sprinzl and Cramer 1975).  
 
 
Figure I.2 Conformation of ATP during binding to aaRS.  (A) The binding of ATP in an 
extended conformation to the active site of the class I tryptophanyl-tRNA synthetase (TrpRS) is 
shown on the left (PDB file: 1MAU) (Retailleau et al. 2003).  The enzyme is highlighted in 
yellow and the ATP in blue. (B) The binding of ATP in a bent conformation to the active site of 
class II AlaRS is shown on the right (PDB file: 1YFR) (Swairjo and Schimmel 2005).  The 
enzyme is highlighted in red and the ATP in blue.  
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I.3 Hydrolytic Editing of LeuRS 
In order to ensure the highest level of fidelity during protein synthesis, some aaRSs have 
developed editing mechanisms to clear errors during the charging of tRNA              
(Hendrickson and Schimmel 2002; Geslain and Ribas de Pouplana 2004; Mascarenhas et al. 
2008).  Linus Pauling first predicted an error rate of 1 in 20 during protein synthesis when he 
projected a general inability of enzymes to distinguish fully between structurally similar amino 
acids that differed from each other by only a methyl group (Pauling 1958) (Figure I.3).  
However, Loftfield later measured the error rate for the misincorporation of valine for 
isoleucine in chicken ovalbumin to be much lower at an occurrence of less than 1 in 3000 
(Loftfield 1963).  In order to reconcile the projected error rate with high discrimination rate, 
Alan Fersht proposed that some aaRSs possess a secondary editing site where corrections can be 
made to confer a high specificity to the aaRS (Fersht 1977).   
In order to protect against statistical errors that could be incorporated into proteins 
during translation, about half of the family of aaRSs have evolved proofreading mechanisms 
(Hendrickson and Schimmel 2002; Mascarenhas et al. 2008).  These fidelity mechanisms are 
critical to the cell.  Defects in aaRS editing result in cell death (Karkhanis et al. 2006;        
Nangle et al. 2006; Karkhanis et al. 2007) and have been shown to cause neurological disease in 
mammals (Lee et al. 2006).   
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Leucine      Isoleucine      Valine       Norvaline    Methionine 
 
Figure I.3 Structurally similar amino acids.  The red balls represent oxygen, the blue balls 
nitrogen, the yellow ball sulphur, the larger gray balls carbon, and the small gray balls 
hydrogen.  
 
Alan Fersht hypothesized that some aaRSs, including isoleucyl-tRNA synthetase (IleRS) 
(Baldwin and Berg 1966), and valyl-tRNA synthetase (ValRS) (Fersht and Kaethner 1976) 
function via a double sieve mechanism in order to maintain fidelity (Fersht and Dingwall 1979).  
In this model, the aminoacylation active site serves as a coarse sieve for amino acid activation 
in the canonical core, for example, to exclude bulky amino acids, but allow smaller isosteric 
amino acids to pass through.  The second hydrolytic active site operates as a fine sieve to bind 
to mischarged amino acid for hydrolysis, while correctly charged tRNAs are released to 
elongation factors (Figure I.4).   
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Figure I.4 T. thermophilus LeuRS crystal structure and cartoon of double sieve model. The 
overall structure of T. thermophilus LeuRS is shown on the left (A). Residues that impact 
editing function are shown in orange. The CP1 domain, β-strands, and the aminoacylation core 
domain are highlighted in blue, green, and red respectively. The double sieve model is shown 
on the right (B). LeuRS functions as a double sieve whereby the aminoacylation core domain 
serves as a “coarse sieve” that excludes larger amino acids and the editing active site acts as a 
“fine sieve” that blocks out cognate amino acid but allows non cognate amino acids to be 
hydrolyzed. The red region represents the coarse sieve while the blue region represents the fine 
sieve.  Structure on left (PDB: 2BTE) adapted from (Tukalo et al. 2005) and cartoon on the 
right adapted from (Mursinna and Martinis 2002).  
 
The aaRSs edit by different pathways: Pre-transfer and post-transfer of charging to the 
tRNA.  In pre-transfer editing, misactivated amino acid is cleaved to release AMP and free 
amino acid.  Post-transfer editing hydrolyzes mischarged tRNA to yield free tRNA and           
non-cognate amino acid (Figure I.5).  It has been proposed that one editing pathway dominates 
over the other (Englisch et al. 1986; Williams and Martinis 2006).  However, the exact relative 
contribution of each pathway toward fidelity is still largely unclear.     
Some enzymes have been shown to activate a second editing pathway in the failure of 
the dominant editing pathway.  For example, when the post-transfer editing active site of 
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Escherichia coli (E. coli) LeuRS is removed, the enzyme maintains overall fidelity through the 
activation of a pre-transfer editing pathway (Boniecki et al. 2008).  Likewise, when post-
transfer editing in the human cytoplasmic LeuRS (hscLeuRS) is mutationally knocked out, the 
enzyme fails to mischarge tRNA, indicating the activation of a second editing pathway to 
maintain overall accuracy (Chapter III) (Pang and Martinis 2009). 
 
Fig I.5 Two editing mechanisms of aaRSs.  Post-transfer editing occurs when the incorrectly 
charged tRNA gets hydrolyzed by the aaRS while pre-transfer editing occurs when the activated 
amino acid is cleaved to form free amino acid and AMP.  
 
A number of aaRSs carry out proofreading functions in cis via a domain that possesses 
editing activity, which is inserted into the catalytic core (Hendrickson and Schimmel 2002).  
However, some archaea as well as bacterial aaRSs lack an editing domain that ensures fidelity 
during protein synthesis.  In order to compensate for this, independent paralogs and homologues 
of editing domains possessing hydrolytic editing activity have been found to occur naturally.  
An example is the ProRS editing domain homologue YbaK that can edit mischarged              
Ala-tRNAPro and Cys-tRNAPro in Haemophilus influenzae (Wong et al. 2003;                                  
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An and Musier-Forsyth 2004).  Additionally, ProX, a paralog of the ProRS editing domain from 
Clostridium sticklandii hydrolyzes Ala-tRNAPro (Ahel et al. 2003), while AlaX, an AlaRS 
homolog from Methanosarcina barkeri and Sulfolobus solfataricus cleaves mischarged          
Ser-tRNAAla and Gly-tRNAAla (Ahel et al. 2003; Chong et al. 2008). 
In either the case of cis or trans editing, the mischarged 3’ end of the tRNA must be 
transferred from the aminoacylation to the editing active site.  X-ray crystallography suggests 
that the 3’ end of tRNA must swing approximately 30 Å from the aminoacylation core domain 
to the CP1 domain of the enzyme via its β-strands (Figure I.6) (Tukalo et al. 2005).  The 
flexibility of these β-strands connecting the aminoacylation core domain to the editing domain 
is essential for translocation and editing.  Substitution of a specific glycine within the β-strands 
disrupted tRNA translocation (Mascarenhas and Martinis 2009).  A “translocation peptide” 
within the CP1 domain of E. coli LeuRS also facilitates transfer of tRNA from the canonical 
core to the CP1 domain (Hellmann and Martinis 2009).  Comparison of the crystal structures of 
LeuRS in various states of binding to tRNA suggested that the CP1 domain rotates through the 
different stages of aminoacylation and its movement is dependent on the flexibility of the β-
strands (Mascarenhas and Martinis 2008). 
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Figure I.6 Crystal structure of T. thermophilus LeuRS.  The CP1 domain of LeuRS rotates 35° 
relative to the canonical core during the translocation of tRNA, PDB entry 2BTE.               
(Tukalo et al. 2005).  
 
I.4. Aminoacyl-tRNA Synthetase Recognition of tRNA 
 
In general, tRNAs have similar secondary as well as tertiary structure (Figure I.7)     
(Kim 1979).  Thus, the aaRSs depend on embedded identity elements within the tRNA substrate 
to recognize and differentiate their cognate substrate for aminoacylation                               
(Hou and Schimmel 1988; McClain and Foss 1988; Normanly et al. 1992).  Certain structural 
features of the aaRS can also play an important role in ensuring specificity during tRNA 
binding.  For example, the tRNA acceptor stem binds to the canonical core domain of a specific 
aaRS.  In some class I aaRSs, a zinc binding domain is important for the binding of the acceptor 
stem of tRNA (Fourmy et al. 1995; Liu et al. 1995; Glasfeld and Schimmel 1997). 
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Figure I.7 Secondary and tertiary structure of tRNA.  The secondary cloverleaf structure of 
tRNA is shown on the left with the anticodon-loop nucleotides shaded in red, while the tertiary 
structure of tRNA is shown on the right, where orange represents the 3’ acceptor end, purple the 
acceptor stem, green the TψC stem, red the dihydrouridine (DHU) stem, yellow the variable 
loop, blue the anticodon loop and black the anticodon nucleotides.    
 
Identity elements on the tRNA enable a precise and complementary interaction between 
the aaRS and tRNA.  The tRNA identity elements mostly cluster in the anticodon or acceptor 
stem region of the tRNA (Giegé et al. 1998).  Some of these identity elements include single 
nucleotide variations, such as the discriminator base N73 in the acceptor stem of the tRNA that 
serves as a recognition factor to many aaRSs (Crothers et al. 1972).  Also, unique base pairs in 
helices, particularly in the acceptor stem, ensure that tRNAs bind to their corresponding aaRS 
(Ibba and Söll 2004).  Some other tRNAs, such as tRNASer, rely on recognition elements in its   
D-stem and its long variable loop (Achsel and Gross 1993). 
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Anticodon nucleotides of tRNA are important for aaRS recognition as they ensure 
specific interaction between the aaRS and its cognate tRNA.  The only exceptions are tRNALeu, 
tRNASer, and tRNAAla (Asahara et al. 1993; Asahara et al. 1993; Giegé et al. 1998).  These 
tRNAs have many multiple isoacceptors with too different anticodon nucleotides to provide a 
unique anticodon-aaRS match.  In the case of tRNALeu, the N73 discriminator base is primarily 
responsible for conferring specificity (Asahara et al. 1993; Breitschopf and Gross 1996;      
Soma et al. 1996).  In addition, the E. coli tRNALeu relies on the triple interaction that is formed 
between A15:U48, and A20a at the D- and T-arms of tRNA, as well as the invariant G18G19               
(Asahara et al. 1993; Asahara et al. 1998; Larkin et al. 2002) to form a unique structural motif 
for recognition by LeuRS. 
Anti-determinants on the other hand prevent the productive interaction between aaRS 
and a non-cognate tRNA.  The first anti-determinant was identified at position 34 of E. coli 
tRNAIle which contains a lysidine, a modified cytosine, that hinders misaminoacylation by 
methionyl-tRNA synthetase (MetRS) (Muramatsu et al. 1988).  Other examples of anti-
determinants include modified nucleotide m1G37 in yeast tRNAAsp that hinders aminoacylation 
by arginyl-tRNA synthetase (ArgRS) (Perret et al. 1990; Putz et al. 1994).  In addition, the G37 
nucleotide on tRNASer prevents charging by yeast LeuRS (Breitschopf et al. 1995).  Finally, the 
A73 nucleotide on tRNALeu inhibits aminoacylation by SerRS (Soma et al. 1996).  
Some tRNA structural motifs can function as recognition elements for aaRSs.  One 
instance involves tRNAAla where the G3:U70 wobble pair causes a slight distortion in its 
acceptor helix causing it to complement the structure of AlaRS (McClain et al. 1988).  Another 
example is the tRNASer whereby T. thermophilus SerRS recognizes tRNASer by its shape via 
backbone interactions (Biou et al. 1994).  
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I.5. Brief Overview of Eukaryotic LeuRS in its Macromolecular Complex 
 
 In higher eukaryotes, nine aaRSs are assembled into a multi-aaRS complex.  This 
macromolecular complex consists of nine different enzymes including ArgRS, aspartyl-tRNA 
synthetase (AspRS), GlnRS, glutamyl-prolyl tRNA synthetase (Glu-ProRS), IleRS, LeuRS, 
LysRS, and methionyl-tRNA synthetase (MetRS).  A 30 Å cryo-electron microscopy (EM) 
structure of the multi-aaRS complex is shaped like an asymmetric triangle with dimensions of 
approximately 19 nm x 16 nm x 10 nm.  A central cleft that is 4 nm diameter deep extends 
about two-thirds of the length of the complex (Norcum and Warrington 1998;                               
Norcum and Boisset 2002).   
Three auxiliary non-synthetase proteins, p18, p38, and p43, now known as aminoacyl-
tRNA synthetase interacting multifunctional protein (AIMP) 3, 2, and 1 respectively, are at the 
core that holds the subdomains of the macromolecule together.  It is hypothesized that these 
auxiliary complexes stabilize the whole complex (Lee et al. 2004; Park et al. 2005;        
Kaminska et al. 2009).  Auxiliary protein AIMP1 is located in the mid section of the complex             
(Norcum and Warrington 2000) and interacts with GlnRS and ArgRS (via its N-terminal region) 
to anchor them to the rest of the multi-synthetase complex (Park et al. 1999;                  
Kaminska et al. 2009).  The AIMP3 anchors the MetRS to the other components of the multi-
synthetase complex (Kaminska et al. 2009).  Based on tandem affinity purification from human 
cells, AIMP2, acts as a base for complex assembly (Quevillon et al. 1999; Robinson et al. 2000) 
and connects two sub-complexes, the first comprised of MetRS, AIMP3, Glu-ProRS, IleRS, and 
LeuRS and the second including AIMP1, GlnRS and ArgRS (Kaminska et al. 2009)          
(Figure 1.8).  Auxiliary protein AIMP2 is critical for the assembly of the multi-synthetase 
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complex (Ahn et al. 2003) and links the two subcomplexes with AspRS and LysRS     
(Quevillon et al. 1999; Robinson et al. 2000; Kaminska et al. 2009). 
 
Figure I.8 Organization of the multi-synthetase complex. Schematic representation of the aaRS 
complex consisting of nine aaRSs and three auxiliary proteins in the core that stabilize the 
complex (Kaminska et al. 2009).  Each aaRS is represented by its one-letter amino acid code 
within the circles shaded in blue.  The three auxiliary proteins AIMP1, AIMP2 and AIMP3 are 
shaded in green.  Connectivity between the various synthetases is denoted with black lines.    
 
Certain events prompt individual aaRSs to be released from the multisynthetase 
complex, as in the case of LysRS (Yannay-Cohen et al. 2009).  After the macromolecular 
complex comes apart, the three auxiliary proteins are then released to perform a myriad of cell 
signaling activities (Park et al. 2005; Ray et al. 2007; Kaminska et al. 2009).  Additionally, 
many of the aaRSs that form this complex perform other roles in addition to aminoacylation, 
when they are released from the complex.   
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For example, Glu-ProRS can be switched from its classical role in translation by 
phosphorylation to become a gene-specific modulator of translation (Dever 2002;          
Mazumder et al. 2003).  It forms a complex with ribosomal subunit L13a and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) in response to interferon-γ to trigger translational silencing 
in ceruloplasmin.  The Glu-ProRS complex binds to the 3’-untranslated region of ceruloplasmin 
to block mRNA translation (Sampath et al. 2004).  Specific translational silencing of 
ceruloplasmin has been hypothesized to serve as a feedback mechanism to prevent over-
accumulation of the protein, which might result in oxidative damage                    
(Mukhopadhyay et al. 1997). 
Of all the aaRSs within the complex, LysRS appears to be the most versatile and is 
associated with a myriad of activities.  In an immunological function, LysRS can secrete Ap4A 
in order to activate mast cells.  Once Ap4A is formed, it binds to Hint, which is a tumor 
suppressor gene.  This causes reduced interaction between Hint and microphthalmia 
transcription factor (MITF), causing MITF to be released from the multicomplex to 
transactivate its responsive genes. (Lee et al. 2004).  The LysRS can also act as a pro-
inflammatory cytokine (Park et al. 2005) if its release is induced by tumor necrosis factor α 
(TNF-α).  This secreted LysRS can bind macrophages in order to enhance TNF-α production 
and migration (Park et al. 2005; Nechushtan et al. 2009).  
Assembly of the human immunodeficiency virus (HIV) with the viral Gag protein 
(Halwani et al. 2004) is dependent on LysRS that acts as a signal targeting tRNALys for 
incorporation into virions (Gabor et al. 2002; Javanbakht et al. 2002; Cen et al. 2004).  The 
LysRS itself is also selectively packaged into HIV-1 separately from tRNALys (Cen et al. 2001). 
Once tRNALys is inside the virion, it anneals to the genomic DNA of the virus and can be used 
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to prime the reverse transcription of cDNA from the viral RNA genome                                
(Mak and Kleiman 1997).   
I.6. Alternate and Secondary Functions of aaRSs 
 As discussed briefly before, aaRSs may possess secondary functions that are not directly 
related to their aminoacylation role in protein synthesis (Figure 1.9) (Martinis et al. 1999).  
Many of these alternate functions have been implicated in disease states (Martinis et al. 1999).  
Additionally, aaRS-like proteins or paralogs of aaRSs that originate from complete or partial 
gene duplications of the aaRS gene also have adapted for diverse cellular functions        
(Schimmel and Ribas De Pouplana 2000).     
Secondary activities of aaRSs in alternate functions include mitochondrial RNA splicing 
(Dujardin and Herbert 1997), translational regulation (Romby et al. 1996), and transcriptional 
regulation (Putney and Schimmel 1981; Condon et al. 1996).  Neurospora crassa mitochondrial 
TyrRS as well as Saccharomyces cerevisiae and Saccharomyces douglasii mitochondrial LeuRS 
aid in group I intron splicing in the mitochondria (Herbert et al. 1988).  It is proposed that they 
bind introns and promote folding of their cognate introns into an active conformation       
(Caprara et al. 1996; Rho et al. 2002; Boniecki et al. 2009).  In the case of the S. cerevisiae 
mitochondrial LeuRS, the CP1 editing domain is important in splicing mitochondrial introns 
(Rho et al. 2002).  LeuRSs from diverse origins can substitute for the mitochondrial LeuRS in 
the splicing reaction.  In contrast, the N. crassa TyrRS is dependent on a small idiosyncratic           
N-terminal domain for splicing activity (Cherniack et al. 1990).  The N-terminal domain is 
largely comprised of an α-helix (Paukstelis et al. 2005) and X-ray crystal structures indicate that 
TyrRS binds to the group I intron with a newly evolved surface that is different from where it 
binds tRNATyr during aminoacylation (Paukstelis et al. 2008).  This N-terminal region, together 
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with the nucleotide-binding fold domain, and C-terminal RNA-binding domain of TyrRS are 
believed to promote splicing (Cherniack et al. 1990; Mohr et al. 2001).  
 
Figure I.9 Non-canonical activities of aaRSs.  The aaRSs may be adapted for dual roles that 
coexist with their aminoacylation activity (Martinis and Pang 2007). 
 
Several aaRSs charge non-canonical tRNA-like substrates. For example, E. coli AlaRS 
aminoacylates transfer-messenger RNA (tmRNA).  A tmRNA is so named because of its tRNA- 
and messenger RNA (mRNA)-like properties that enable it to code and translate specific 
peptides (Atkins and Gesteland 1996; Jentsch 1996).  The tmRNA facilitates release of stalled 
ribosomes from truncated mRNAs that lack a stop codon (Keiler et al. 1996).  It enables 
ribosome recycling by switching the ribosome from the damaged mRNA to tmRNA to code for 
a C-terminal peptide tag, targeting the protein for degradation by proteases (Keiler et al. 1996) 
(Figure I.10).   
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Figure I.10 Model of peptide tagging by tmRNA.  (A) The tRNA in the ribosome reads mRNA. 
(B) The tmRNA is recognized by the ribosome (C) Damaged mRNA is expelled and tmRNA 
provides the mRNA template. (D) Translation of the tmRNA tag occurs. (E) Release factor 
releases the tagged protein. (F) The tagged protein is recognized by proteases and degraded. The 
mRNA is shaded in green, the tRNA in red, the tmRNA in black, the ribosome in orange, the 
protein and amino acids in blue, and the release factor is shaded in purple (Keiler et al. 1996).  
 
The E. coli AlaRS acts as a transcriptional regulator of its own gene when the enzyme 
binds to a palindromic sequence that flanks its promoter site to repress transcription           
(Putney and Schimmel 1981).  The E. coli threonyl-tRNA synthetase (ThrRS) regulates its 
production at the translational level by preventing ribosome binding for translation            
(Romby et al. 1996).  It binds to two stem-loop structures upstream of the ribosome binding 
site, which mimics the anticodon arm of tRNAThr (Romby et al. 1996).   
Many of the aaRSs are also involved in various signaling activities, such as eukaryotic 
tyrosyl-tRNA synthetase (TyrRS) during apoptosis (Wakasugi and Schimmel 1999;      
Wakasugi and Schimmel 1999).  TyrRS splits into two and the N- and C- terminal halves yield 
two distinct cytokines with the C-terminal end upregulating TNF-α and the N-terminal end 
mimicking interleukin-8 that is released by macrophages in an antigen response           
(Wakasugi and Schimmel 1999; Wakasugi and Schimmel 1999).   
Several aaRS-like proteins have been identified that take part in diverse cellular 
activities (Figure I.11) (Schimmel and Ribas De Pouplana 2000).  For example, E. coli YadB 
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protein resembles GluRS and attaches glutamate to a queuosine base (position 34) at the first 
anticodon position of tRNAAsp.  This modification expands and alters the ability of tRNA to 
read codons (Campanacci et al. 2004; Salazar et al. 2004).  Finally, as mentioned before, a 
number of aaRSs that lack an editing domain such as ProRS (Wong et al. 2003) and AlaRS 
(Chong et al. 2008), have paralogs and homologues of editing domains in order to maintain 
overall fidelity (Ahel et al. 2003).  
 
 
Figure I.11 Paralogs of aaRSs.  Paralogs of aaRSs and their domains can provide important non-
aminoacylation functions within the cell. 
 
I.7. Antibiotics Targeting LeuRS 
 The dramatic rise in antibiotic resistant bacteria worldwide poses a serious threat to 
public health.  This situation has fueled the search for antimicrobial agents which target 
essential cell processes but are not resisted by bacteria (Bush 2004).  One of the best known 
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antibiotics that inhibit an aaRS is mupirocin (pseudomonic acid A), which selectively inhibits 
bacterial IleRS (Hughes and Mellows 1978; Hughes and Mellows 1980) and has been used as a 
topical antibiotic against methicillin-resistant Staphylococcus aureus (Sutherland et al. 1985).  
More recently, a small molecule 5-fluoro-1,3-dihydroxy-2,1-benzoxaborole (AN2690) 
has been discovered that targets the editing active site of LeuRS (Figure I.12).  It is an 
antifungal that contains the unusual atom: boron, and kills a range of organisms including 
yeasts, molds and dermatophytes.  The minimum inhibitory concentration (MIC) needed for 
antifungal activity of AN2690 varies from 0.125 µg/mL to 2 µg/mL with dermatophytes having 
a generally higher MIC (Table 1.2) (Baker et al. 2006).  
 
 
 
Figure I.12 Structure of boron-containing AN2690. 
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Table I.2 Table of broad-spectrum antifungal activity of AN2690 
Fungi MIC (µg/mL) 
Yeasts   
Saccharomyces cerevisiae 0.125 
Candida albicans 0.5 
Candida krusei 1 
Candida tropicalis 0.25 
Cryptococcus neoformans 0.25 
Malassezia furfur 1 
Malassezia pachydermatis 1 
Molds   
Aspergillus fumigatus 0.25 
Rhizopus microsporus 2 
Alternaria alternata 0.5 
Penicillium chrysogenum 2 
Cladosporium cladosporioides 0.5 
Fusarium solani 2 
Dermatophytes   
Trichophyton rubrum 2 
Trichophyton mentagrophytes 2 
Epidermophyton floccosum 1 
Microsporum audouinii 2 
Microsporum gypseum 2 
 
The boron containing AN2690 traps tRNALeu within the editing active site of LeuRS.  
The boron atom in AN2690 attacks one of the ribose cis diols of the 3’ adenosine in tRNA and 
then forms an oxaborole adduct with the ribose.  Water molecules in the editing pocket stabilize 
the negatively charged boron atom (Rock et al. 2007) (Figure 1.13).  The cross-linked editing 
complex impedes overall aminoacylation of tRNALeu.  Thus protein synthesis within the cell 
ceases to occur.  Therefore, the incorporation of boron atoms into rationally designed inhibitors 
represents a promising future for the development of new classes of therapeutic agents.  
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Figure I.13 Reaction mechanism of AN2690.  Attack by the AN2690 boron on either the 3’ OH 
on the 3’ adenosine of tRNA (A) or the 2’ OH on the 3’ adenosine of tRNA (B).  Water is 
present to help stabilize the negatively charged boron atom (Rock et al. 2007).  Reproduced 
with permission. 
 
 
Protein synthesis is one of the most fundamental reactions in the cell that ensures its 
viability.  It is evident that aaRSs require an editing function in order to ensure accurate protein 
synthesis and overall health of the cell.  In view of this, I proposed to characterize the 
aminoacylation as well as editing function of hscLeuRS.  As discussed earlier, hscLeuRS is part 
of a macromolecular complex in the cell, many components of which participate in alternate 
functions apart from translation.  I characterized its editing activity and determined that there is 
a paradigm shift in the amino acid editing mechanism of hscLeuRS.  I hypothesize that 
hscLeuRS carries out pre-transfer editing in the absence of post-transfer editing, indicating the                   
re-emergence of a more redundant fidelity pathway.   
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 Translocation of tRNA from the canonical core domain to the editing active site is 
critical for accurate charging to occur (Hellmann and Martinis 2009;                         
Mascarenhas and Martinis 2009).  The E. coli LeuRS was chosen as a model to study the 
protein-protein interactions that occur between the aminoacylation core domain and the editing 
domain in order to facilitate translocation of tRNA.  I hypothesize that molecular crosstalk 
between the main body of the enzyme and CP1 domain takes place to ensure the successful 
translocation of tRNA.  Immunoprecipitation pull-down assays as well as single molecule 
fluorescence resonance energy transfer (smFRET) experiments have been conducted to study 
the global interaction between the core and editing domain during the movement of the 3’ end 
of tRNA into the editing pocket of LeuRS.      
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Chapter II. Materials and Methods 
II.1. Materials 
Oligonucleotide primers were purchased from Integrated DNA Technologies 
(Coralville, IA).  Restriction enzymes DpnI and BstNI were obtained from Promega     
(Madison, WI) and New England BioLabs Inc. (Beverly, MA) respectively.  Cloned Pfu DNA 
polymerase and dNTP mix were acquired from Stratagene (La Jolla, CA).  Crude calf liver 
tRNA was purchased from Novagen (San Diego, CA).  Tritium-labeled amino acids, as well as 
[32P]-ATP and [32P]-PPi, were obtained from Amersham Pharmacia Biotech (Piscataway, NJ).  
II.2. Mutagenesis 
Site directed mutagenesis was performed via the polymerase chain reaction (PCR). Each 
50 µL PCR mixture contained 50 ng of DNA template, 100 ng each of forward and reverse 
primer, 200 µM dNTPs, and 2.5 U of Pfu DNA polymerase in commercial buffer.  Each PCR 
reaction was carried out at 95°C for 30 sec; 55°C for 30 sec; and 68°C for 30 min for one cycle, 
and then 16 cycles at 95°C for 30 sec, 58°C for 30 sec and 68°C for 22 min.  The reaction was 
completed with a final incubation at 68°C for 22 min.  A restriction digestion of each PCR 
mixture with 20 units of DpnI was carried out for 4 h at 37 °C and then used for transformation 
of E. coli DH5α.  The mutant sequences of the LeuRS genes were confirmed by DNA 
sequencing (UIUC Core Sequencing Facility, Urbana, IL).  
II.3. Protein Expression and Purification  
Mutant and wild-type plasmids were used to transform E. coli strain BL21 (DE3) codon 
PLUS (Stratagene).  A single colony was used to inoculate a 3 mL culture of LB with             
100 µg/mL ampicillin and grown overnight at 37 °C.  This 3 mL aliquot was then transferred to 
1 L of LB containing 100 µg/mL ampicillin and grown at 37 °C until the OD600 was between 0.4 
26 
 
and 0.6.  Protein expression was induced for 3 h at 37 °C by the addition of 1 mM isopropyl β-
D-1-thiogalactopyranoside (IPTG). 
The cells were then harvested by centrifugation at 6000 rpm for 15 min in an Avanti J-E 
centrifuge (Beckman Coulter, Fullerton, CA).  The cell pellet was resuspended in 7 mL of HA-1 
buffer (20 mM NaPi, 10 mM tris(hydroxymethyl)aminomethane (Tris), pH 8.0, 300 mM NaCl,   
5 mM imidazole, and 5% glycerol) and then sonicated once at 50% power using a Vibra Cell 
sonicator (Sonic, Newtown, CT).  The lysate was spun at 12,000 rpm for 30 min at 4 °C.  The 
supernatant was collected and the pellet discarded.   
The supernatant containing protein was combined with a HIS-Select HF Nickel Affinity 
(Sigma, St, Louis, MO) resin that had been pre-equilibrated with HA-1 buffer.  The supernatant 
was rocked gently with the nickel resin for 2 h at 4 °C to allow for the N-terminal fused six-
histidine tag on each protein to bind to the resin.  The resin was then washed with a total of     
100 mL HA-2 buffer (20 mM NaPi, 10 mM Tris, pH 8.0, 500 mM NaCl, 5 mM imidazole, and 
5% glycerol) and the protein was eluted with 10 mL 100 mM imidazole in HA-1 buffer.  The 
protein solution was dialyzed against a 100 mM KPi, pH 6.8, 10 mM β-mercaptoethanol buffer 
for 24 h with six changes of buffer.  The protein was later stored at -20 °C and in 50% glycerol.  
The concentration of protein was determined on the basis of its absorbance at 280 nm and 
calculated using an estimated extinction coefficient specific for the protein as computed by the 
ExPASy Protparam tool (http://ca.expasy.org/tools/protparam.html). 
II.4. Preparation and Purification of T7 RNA Polymerase Transcribed tRNA  
 
 The E. coli tRNAUAA (tRNALeu) was transcribed from plasmid ptDNAleu14              
(Tocchini-Valentini et al. 2000) that encoded the gene for E. coli tRNALeu.  A total of 450 µg of 
plasmid ptDNAleu14 was first digested overnight with 25 units of BstNI at 60 °C in a total 
 Leu  
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volume of 1 mL and then used as a template for run-off transcription                              
(Sampson and Uhlenbeck 1988).  The T7 RNA polymerase was expressed from plasmid 
p6HRNAP (Gift from Dr. K. Musier-Forsyth, Ohio State University; Columbus, OH) for three 
hours at 37 °C with 1 mM IPTG and then purified over a nickel His-selectTM column.  Each 
transcription mixture contained 40 mM Tris, pH 8.0, 30 mM MgCl2, 5 mM dithiothreitol 
(DTT), 0.01% Triton X-100, 50 µg/mL bovine serum albumin (BSA), 4 mM of each NTP,       
80 mg/mL PEG8000, 0.02 units/µL RNase inhibitor (Eppendorf, Hamburg, Germany), 2 mM 
spermidine, 0.01 mg/mL pyrophosphatase (Sigma, St. Louis, MO), and 0.8 µM T7 RNA 
polymerase.  The reaction mixtures were incubated at 42 °C for 3 h followed by a second 
addition of 0.8 µM of T7 RNA polymerase, and then incubated for an additional 3 h period.   
The reactions were precipitated with twice the volume of 100% ethanol and with         
167 µg/mL glycogen as a carrier at -80 °C for at least 30 min.  The RNA products were purified 
by electrophoresis on a 10% polyacrylamide gel that contained 8 M urea.  The tRNALeu band was 
visualized by UV shadowing and excised from the gel.  The excised gel was crushed and soaked 
in 0.5 M NH4OAC and 1 mM ethylenediaminetetraacetic acid (EDTA), pH 8.0 and rocked 
gently at 37 °C to extract the tRNA.  The supernatant was collected and the gel extracted two 
more times.  Butanol extraction was used to concentrate the tRNA, which was then ethanol 
precipitated and resuspended in nuclease-free water (Ambion, Austin, TX).  The concentration 
of the tRNA was calculated based on its extinction coefficient of 840,700 liters/mol·cm          
(Puglisi and Tinoco 1989).   
II.5. Aminoacylation and Misaminoacylation Assays  
Each aminoacylation reaction contained 50 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid-KOH (HEPES), pH 7.6, 30 mM KCl, 30 mM MgCl2, 0.02% 
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BSA, 1 mM DTT, 4 µM in vitro transcribed tRNALeu, 22 µM [3H]-leucine (158 Ci/mmole) and 
50 nM enzyme.  Misaminoacylation assays were carried out in the same manner except with     
1 µM enzyme, 4 µM E. coli transcribed tRNALeu and 22 µM [3H]-isoleucine (93 Ci/mmole).  
Reactions were initiated with 4 mM ATP and carried out in a 30 °C heat block.  Aliquots of     
10 µL were taken at different time points and quenched on Whatman filter pads that were pre-
soaked with 5% trichloroacetic acid (TCA).  The pads were washed three times for 10 min each 
with cold 5% TCA, once with cold 70% ethanol, and once with anhydrous ether.  The washed 
pads were then dried under a heat lamp. Radioactivity was quantified in a Beckman LS 6000IC 
scintillation counter (Beckman Coulter, Fullerton, CA).        
II.6. Isolation of Charged tRNALeu  
Transcribed E. coli tRNALeu at a final concentration of 8 µM was aminoacylated with      
1 µM wild-type E. coli LeuRS or misaminoacylated with 1 µM editing-defective E. coli LeuRS 
in a reaction containing 60 mM Tris, pH 7.5, 10 mM MgCl2, 1 mM DTT, 22 µM [3H]leucine or 
isoleucine, and 4 mM ATP.  The reactions were carried out at room temperature for either        
60 min (aminoacylation) or 180 min (misaminoacylation) and then quenched with 0.18% acetic 
acid (Schreier and Schimmel 1972).  Protein was removed from the mixture by a 
phenol/chloroform/isoamyl alcohol mixture (125:24:1; Fisher Biotech, Fair Lawn, NJ) at pH 
4.3.  The charged tRNA was then ethanol precipitated and resuspended in 50 mM KPi, pH 5.0.                                                                          
II.7. Post-transfer Editing Assay 
Deacylation reactions each contained 60 mM Tris, pH 7.5, 10 mM MgCl2, 300 mM KCl, 
and approximately 4 µM of [3H]-Ile-tRNALeu or [3H]-Leu-tRNALeu.  Reactions were conducted 
in a 30 °C heat block and initiated with 50 nM enzyme.  Aliquots of 10 µL were taken at 
29 
 
different time points and quenched on Whatman filter pads that were pre-soaked with 5% TCA.  
The pads were washed and analyzed as described above.  
II.8. Inorganic Pyrophosphate (PPi) Exchange Assay 
Reactions containing 50 mM HEPES (pH 8.0), 10 mM MgCl2, 300 mM KCl, 1 mM 
DTT, 1 mM [32P]-PPi (78 mCi/mL; Amersham Pharmacia Biotech), 1 mM leucine, and 1 µM 
enzyme were initiated with 1 mM ATP.  Aliquots of 2 µL were taken at different time points 
and spotted on a cellulose polyethyleneimine (PEI) thin-layer chromatography (TLC) plate 
(Scientific Adsorbents Inc., Atlanta, GA).  The reaction components were separated by TLC in 
750 mM KH2PO4 (pH 3.5) and 4 mM urea (Hsu et al. 2006).  The separated radiolabeled bands 
were visualized by phosphorimaging using a FUJIX BAS 1000 film (FUJI-FILM Medical 
Systems U.S.A., Stanford, CT) and quantified with a Storm 840 Molecular Dynamics imager 
(GE Healthcare, Piscataway, NJ). 
II.9. ATPase Assay 
Each reaction mixture contained 100 mM Tris, pH 7.5, 20 mM MgCl2, 10 mM DTT,       
5 mM amino acid, 36.2 µM α-[32P]-ATP (3000 Ci/mmole), and 10 µM E. coli transcribed 
tRNA.  The reactions were initiated with 1 µM enzyme.  Aliquots of 2 µL were taken at 
different time points and spotted on a cellulose PEI TLC plate (Scientific Adsorbents Inc., 
Atlanta, GA).  The reaction components were separated by TLC in 750 mM KH2PO4 (pH 3.5).  
The separated radiolabeled bands were visualized by phosphorimaging using a FUJIX BAS 
1000 film (FUJI-FILM Medical Systems U.S.A., Stanford, CT) and quantified with a Storm 840 
Molecular Dynamics imager (GE Healthcare, Piscataway, NJ).  
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Chapter III. Paradigm Shift in the Amino Acid Editing Mechanism of Human   
Cytoplasmic LeuRS  
 
Reproduced with permission from the American Chemical Society 
Pang, Y. L. and S. A. Martinis (2009). "A paradigm shift for the amino acid editing mechanism 
of human cytoplasmic leucyl-tRNA synthetase." Biochemistry 48(38): 8958-64.  Copyright 
2009 American Chemical Society 
 
III.1. Introduction 
The aaRSs establish the genetic code by accurately linking the correct tRNA to its 
cognate amino acid in the first step of translation (Ibba and Söll 2004; Mascarenhas et al. 2008).  
As discussed in the introduction, each aaRS ensures that the tRNA is correctly charged in a two-
step reaction mechanism.  The charged tRNAs are then shuttled to the ribosome via elongation 
factors.  
The editing active site for the CP1 domains of IleRS, ValRS and LeuRS are comprised 
of conserved peptides that are only partially differentiated to confer specificity                      
(Zhai et al. 2007).  Each contains a universally conserved aspartic acid that is essential for 
hydrogen bonding to the amino group of the bound amino acid (Figure III.1).  Hydrolytic 
editing activity is abolished when the aspartate is substituted by an alanine in LeuRS   
(Lincecum et al. 2003), ValRS (Fukunaga and Yokoyama 2005), and IleRS                      
(Bishop et al. 2002).   
In addition, a threonine-rich region is important for catalysis and substrate specificity.  
One of these threonines in LeuRS functions specifically as a specificity determinant.  
Substitution of this conserved threonine with an alanine abolishes editing specificity by 
removing a steric hindrance in the editing pocket to facilitate leucine binding                
(Mursinna et al. 2001).  Thus, correctly charged Leu-tRNALeu is hydrolyzed in the second sieve 
before undergoing product release.  Substitution of this conserved threonine with a bulky 
31 
 
residue in E. coli LeuRS blocks amino acid editing resulting in a mischarging phenotype            
(Mursinna and Martinis 2002; Tang and Tirrell 2002).  
 
Figure III.1 Multiple sequence alignment of the LeuRS editing pocket.  Sequence alignment of 
conserved regions within the LeuRS editing pocket.  The threonine specificity determinant     
(Thr 298) and universally conserved aspartate (Asp 399) in hscLeuRS are indicated by arrows.  
Highly conserved residues are highlighted in black.  Two shades of gray distinguish 
homologous amino acid sites.  Abbreviations are as follows: Hs, Homo sapiens; Bt, Bos taurus; 
Rn, Rattus norvegicus; Ec, E. coli; Tt, T. thermophilus; Mt, Mycobacterium tuberculosis;                           
Sc, Saccharomyces cerevisiae; Nc, Neurospora crassa; c, cytoplasmic;  and m, mitochondrial. 
 
In many higher organisms, and even some archaea and yeast, aaRS operates as a large or 
small complex.  For example, in human cells, the aaRS macromolecular complex contains nine 
aaRSs including the Lys-, Asp-, Met-, Glu-Pro-, Ile-, Leu-, Arg-, and Glu-tRNA synthetases 
(Norcum and Boisset 2002).  We wondered if viable editing mechanisms that typically reside in 
separate domains such as the CP1 editing module might be maintained in human aaRSs that are 
confined to the complex.  The primary structure of hscLeuRS retains key amino acids in the 
editing active site that are important to bacterial LeuRS editing activities, although other sites 
within the region have diverged.  For example, recent crystal structure information of the 
hscLeuRS editing domain shows that two residues have diverged to bulkier residues, leading to 
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a smaller hydrophobic pocket within the CP1 domain of hscLeuRS (Seiradake et al. 2009).  
Eukaryotic cytosolic LeuRS has also been found to contain an I4 insertion in the CP1 domain 
that was hypothesized to function as a lid by closing over the editing pocket.  This would result 
in a capped tighter hydrophobic editing pocket for hscLeuRS compared to the more spacious 
bacterial LeuRS pocket that is open to the environment (Seiradake et al. 2009).  We cloned the 
hscLeuRS gene and expressed it in E. coli independent of the multi-aaRS complex.  Despite 
maintaining key features in the editing active site that are critical to its hydrolytic activity, 
mutational analysis of the human enzyme suggests that it has functionally differentiated to 
maintain fidelity.  
III.2. Experimental Procedures 
III.2.1 RNA Preparation 
The CCA 3’ end of crude calf liver tRNA was added via a nucleotidyl transferase 
reaction.  The plasmid pCCA encoding the nucleotide transferase enzyme was a gift from Dr. P. 
Schimmel (The Scripps Research Institute; La Jolla, CA).  The enzyme was expressed in BL21 
for 3 h at 37 °C with 1 mM IPTG and then purified over a nickel affinity column (Sigma,         
St. Louis, MO).  Each nucleotidyl transferase reaction contained 100 mM glycine, pH 9.0,        
10 mM MgCl2, 1 mM DTT, 100 µM ATP, 100 µM CTP, 10 mg/mL crude calf liver tRNA, 5 
µM    E. coli CCA nucleotidyl transferase and was incubated in a 70 °C heat block for 15 min.  
Protein was removed from the mixture by extraction with phenol/chloroform/isoamyl alcohol 
(125:24:1; Fisher Biotech, Fair Lawn, NJ) that was pre-equilibrated at pH 4.3.  The tRNA was 
then ethanol precipitated and resuspended in nuclease-free water (Ambion, Austin, TX).   
The E. coli tRNALeu was transcribed from the plasmid ptDNAleu14                       
(Tocchini-Valentini et al. 2000) that encoded the gene for E. coli tRNALeu.  A total of 450 µg of 
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plasmid ptDNAleu14 was first digested overnight with 25 units BstNI at 60 °C in a total volume 
of 1 mL and then used as a template for run-off transcription (Sampson and Uhlenbeck 1988) as 
described in Chapter II. 
III.2.2 Mutagenesis  
Site directed mutagenesis was performed via PCR using the template plasmid 
pHSLARS1 that encoded the wild-type hscLeuRS gene.  The plasmid pHSLARS1 was a gift 
from Weimin Mao and MRK Alley (Anacor Pharmaceuticals; Palo Alto, CA) and was utilized 
to make mutants including T298A (pJPT298A) using primers T298A-Fwd (5'-CAG ACC TGA 
GGC CAT GTT TGG GC-3') and T298A-Rev (5'-GCC CAA ACA TGG CCT CAG GTC TG-
3'), T298Y (pJPT298Y) using primers T298Y-Fwd (5'-CAG ACC TGA GTA CAT GTT TGG 
GC-3') and T298Y-Rev (5'-GCC CAA ACA TGT ACT CAG GTC TG-3'), and D399A 
(pJPD399A) using primers D399A-Fwd (5'-CTC CCC TGA TGC TAT TGC TGC CC-3') and 
D399A-Rev (5'-GGG CAG CAA TAG CAT CAG GGG AG-3').  Each 50 µL PCR mixture 
contained 50 ng of DNA template, 100 ng each of forward and reverse primer, 200 µM dNTPs, 
and 2.5 units of Pfu DNA polymerase in commercial buffer.  Each PCR reaction was carried out 
as described before.  
III.2.3 Expression and Purification of hscLeuRS  
Mutant and wild-type plasmids were used to transform E. coli strain BL21 (DE3) codon 
PLUS (Stratagene).  A single colony was used to inoculate a 3 mL culture of LB with             
100 µg/mL ampicillin and grown overnight at 37 °C.  This 3 mL aliquot was then transferred to 
1 L of LB containing 100 µg/mL ampicillin and grown at 37 °C until the OD600 was between 0.6 
and 1.0.  Protein expression was induced overnight at room temperature by the addition of          
1 mM IPTG and processed as described in Chapter II.  The concentration of protein was 
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determined on the basis of its absorbance at 280 nm and calculated using an estimated 
extinction coefficient of 178,080 liters/mol·cm computed by the ExPASy Protparam tool 
(http://ca.expasy.org/tools/protparam.html). 
III.3. Results  
The editing active site within the CP1 domain of LeuRS is marked by conserved peptide 
motifs.  A highly conserved threonine within a threonine-rich region acts as a specificity 
determinant (Figure III.1 and Figure III.2) and blocks leucine from binding for hydrolysis of 
correctly charged Leu-tRNALeu.   
Substitution of this key threonine with a bulky residue such as tyrosine fills up the 
amino acid binding pocket in E. coli LeuRS to prevent editing (Mursinna and Martinis 2002; 
Tang and Tirrell 2002).  In a separate motif, a universally conserved aspartic acid (Figure III.1) 
that is also found in IleRS and ValRS anchors the amino acid via a hydrogen bond with its 
amino moiety in the active site.  Substitution of the aspartic acid by alanine abolishes editing 
activity in LeuRS and IleRS (Bishop et al. 2002; Lincecum et al. 2003;                           
Fukunaga and Yokoyama 2005).   
The threonine specificity determinant and universal aspartic acid are also found in 
hscLeuRS amongst many other conserved features of the editing active site.  This suggests that 
LeuRS from a higher eukaryote maintains fidelity using an editing active site architecture that is 
common to lower organisms. 
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Figure III.2 Crystal structure of hscLeuRS CP1 domain. B. Crystal structure of the hscLeuRS 
CP1 domain (PDB entry 2WFD) showing the editing pocket containing the threonine-rich 
region and the universally conserved aspartate.  Residues Thr 293, Leu 294, Thr 298, Val 392, 
Asp 399, Val 431 and Val 479 are shown in space-filling form.  The atoms are colored as 
follows: oxygen, red; nitrogen, light blue; carbons, gray.  Thr 298 is highlighted completely in 
yellow.  The I4 insertion is highlighted in blue and the editing pocket in green.     
 
We tested this hypothesis by substituting the conserved threonine at position 298 of hscLeuRS 
(Thr 252 in E. coli LeuRS) with an alanine (T298A) and also with a bulky tyrosine (T298Y).  
The universal aspartate at position 399 in hscLeuRS was also substituted with an alanine.  The 
mutant and wild-type proteins were expressed in E. coli and purified by affinity 
chromatography with a six-histidine tag.   
The enzymatic activities for each of the mutants were characterized and compared to 
wild-type hscLeuRS.  Both the T298Y and D399A mutant hscLeuRSs exhibited robust 
aminoacylation of crude calf liver tRNA, albeit the latter activity was reduced compared to    
wild-type (Figure III.3A).  As would be expected based on analysis of other LeuRSs      
(Mursinna et al. 2001), the T298A LeuRS mutant failed to accumulate Leu-tRNALeu           
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(Figure III.3A).  The T298A hscLeuRS mutant also uncouples specificity in the editing active 
site and hydrolyzes Leu-tRNALeu (Figure III.3B).    
 
 
Figure III.3 Leucine aminoacylation and deacylation by wild-type and mutant hscLeuRS.  A. 
Leucylation activity was measured with 500 nM enzyme and 4 mg/ml of crude calf liver tRNA 
(Novagen, Gibbstown, NJ).  B. Post-transfer editing reactions were carried out with 500 nM 
enzyme and ~4 µM E. coli Leu-tRNALeu.  All enzyme reactions were incubated at 30 °C.  Wild 
type (WT) and mutant proteins are represented by the following symbols: WT, (   ); T298A,       
(   ); D399A, (   ); T298Y, (   ); and no enzyme, (   ).  Error bars are based on the results of three 
reactions each and indicated for each point. 
 
We wondered if the relatively reduced aminoacylation activities of the D399A LeuRS mutant 
enzyme might be due in part to changes in the first step of amino acid activation step even 
though the mutation is located in the CP1 domain, which is completely separate from the 
canonical aminoacylation core.  Pyrophosphate exchange assays determined that the D399A 
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LeuRS mutant activated leucine at reduced rates (Figure III.4).  The decrease in leucine-
dependent pyrophosphate exchange activity by the distal D399A mutation was largely due to a 
KM effect (Table III.1).  The KM was about 40-fold higher for leucine activation by the D399A 
LeuRS mutant (0.9 + 0.2 mM) as compared to the human wild-type enzyme                         
(0.024 + 0.009 mM).  The kcat for leucine activation of the wild type and mutant enzymes were 
2.1 + 0.4 s-1 and 5.6 + 0.1 s-1, respectively. This reduction in amino acid activation activity is 
consistent with the lower levels of leucylation activity for the D399A LeuRS mutant compared 
to the wild-type enzyme.  These results suggest that a long-distance inter-domain 
communication mechanism for the protein exists between the aminoacylation and amino acid 
editing active site that is at least partially tRNA-independent. 
 
 
Figure III.4 Pyrophosphate (PPi) exchange activity of wild type and D399A hscLeuRS.  Leucine 
and isoleucine-dependent PPi exchange assays were carried out with 1 µM hscLeuRS and         
10 mM leucine.  Symbols are as follows: WT with leucine, (    ); and D399A with leucine, (   ). 
Error bars are based on the results of three reactions each and indicated for each point. 
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Table III.1 Apparent kinetic parameters for amino acid activation 
 KM (mM) kcat (s-1) kcat / KM (s-1mM-1) 
Enzyme Leu Ile Leu Ile Leu Ile 
       
Hsc WT 0.02 ± 0.0009 2.04 ± 0.80 2.1 ± 0.4 0.34 ± 0.2 94.3 ± 23.4 0.16 ± 0.04 
       
Hsc D399A 0.90 ± 0.19 3.3 ± 1.2 5.6 ± 0.07 0.51 ± 0.04 5.6 ± 0.40 0.17 ± 0.04 
 
Mischarged E. coli Ile-tRNALeu was isolated to test the wild-type and mutant LeuRSs 
directly for tRNA deacylation activity.  The D399A mutant of LeuRS eliminated Ile-tRNALeu 
deacylation activity (Figure III.5), which is consistent with all other alanine substitutions at this 
key site in LeuRS (Lincecum et al. 2003), IleRS (Bishop et al. 2002) and ValRS            
(Fukunaga and Yokoyama 2005).  In contrast though, substitution of the conserved threonine 
with a bulky tyrosine residue (T298Y) in the hscLeuRS maintained Ile-tRNALeu deacylation 
activity.  This suggests that even though the threonine specificity determinant is maintained, the 
architecture around the amino acid binding pocket has changed for the human enzyme.   
 
Figure III.5 Deacylation activity of wild-type and mutant hscLeuRS.  Post-transfer editing 
assays were carried out with 500 nM enzyme and ~4 µM E. coli Leu-tRNALeu at 30 °C.  Wild 
type (WT) and mutant proteins are represented by the following symbols: WT, (   ); T298A,         
(   ); D399A, (   ); T298Y,  (   ); and no enzyme, (  ).  Error bars are based on the results of three 
reactions each and indicated for each point.  
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A recent crystal structure for the CP1 domain of hscLeuRS and the related yeast cytoplasmic 
enzyme showed that the eukaryotic LeuRS CP1 domain has acquired insertions             
(Seiradake et al. 2009).  In particular, the I4 insertion (shown in blue on Figure III.2) is 
juxtaposed to the editing active site and has been hypothesized to act as a lid to sequester 
substrate in the hydrolytic pocket (Seiradake et al. 2009).  It is possible that closing the I4 
insertion lid might promote an induced fit for the mischarged tRNALeu to be edited, even in the 
presence of a bulky residue substitution in the human LeuRS editing site.  
In the absence of deacylation activity, we expected that the mutant D399A hscLeuRS 
would mischarge tRNALeu similar to other editing-defective LeuRSs (Bishop et al. 2002; 
Lincecum et al. 2003; Fukunaga and Yokoyama 2005).  Crude calf liver tRNA was mischarged 
by the D399A LeuRS mutant, but only at low levels (data not shown) despite a robust 
aminoacylation activity (Figure III.3A).  By comparison, crude E. coli tRNA was mischarged at 
higher levels (Figure III.6A) with a kcat of 0.0018 + 0.0005 s-1 by the D399A hscLeuRS mutant, 
albeit more weakly than LeuRS mutants from other origins that had ablated the tRNA 
deacylation activity.  The D399A LeuRS mutant failed to charge isoleucine to in vitro 
transcribed E. coli tRNALeu, even at high concentrations of 1 µM enzyme (Figure III.6B).  This 
suggests that the low levels of mischarging activity are dependent on tRNA modifications.  It is 
possible that these RNA modifications stabilize tertiary structure to facilitate RNA-protein 
interactions for aminoacylation.  As would be expected, wild-type hscLeuRS maintained 
fidelity and did not mischarge crude or transcribed E. coli tRNA.   
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Figure III.6 Mischarging activity of wild type and mutant hscLeuRS with transcribed and crude 
E. coli tRNA.  A. Misaminoacylation reactions were carried out with 1 µM enzyme and 20 µM 
of in vitro transcribed E. coli tRNA.  B. Misaminoacylation reactions were carried out with       
1 µM enzyme and 4 mg/ml of crude E. coli tRNA.  Wild type (WT) and mutant proteins are 
represented by the following symbols: WT, (   ); D399A, (   ) and an editing-deficient E. coli 
LeuRS mutant, (    ).  Error bars are based on the results of three reactions each and indicated 
for each point. 
 
We hypothesized that, similar to the long-distance effect by the D399A mutation on 
leucine activation (Figure III.4), isoleucine activation might also be significantly reduced, 
resulting in only low mischarging activities for the editing-defective enzyme.  However, the 
D399A mutation had a much less pronounced effect on the KM and kcat for isoleucine-dependent 
pyrophosphate with kcat / KM values that were nearly equivalent for the wild type and mutant 
enzymes (Table III.1).  
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Thus, these long distance inter-domain effects between the editing and aminoacylation 
active sites are sensitive to the cognate amino acid.  It is also possible that low 
misaminoacylation activity by the D399A hscLeuRS could be due to a redundant fidelity 
mechanism that originates in the aminoacylation active site.  In the absence of tRNA, isoleucine 
stimulated the D399A mutant hscLeuRS to form AMP with a kcat of 0.06 + 0.02 s-1 and KM of   
1.8 + 0.5 mM in ATPase assays.  If this represents a case of a putative pre-transfer editing 
pathway, then the mechanism would be independent of the D399A mutation in hscLeuRS since 
the activated isoleucyl-adenylates would be directly cleaved or expelled from the 
aminoacylation active site.  As hypothesized, ATPase assays indicate higher levels of AMP 
production with the D399A mutant as compared to the wild type enzyme due to the hydrolysis 
of misactivated non-cognate amino acid adenylates in the presence of a pre-transfer editing 
pathway.  In particular, pre-transfer edting appears to be tRNA dependent as there is a more 
robust production of AMP in the presence of E. coli transcribed tRNA (Figure III.7). 
 
Figure III.7 ATPase activity assay with wild-type and mutant hscLeuRS.  The ATPase assays 
were carried out with 1 µM enzyme and 5 mM of isoleucine in the absence or presence of 10 
µM E. coli Leu-tRNALeu.  Wild type (WT) and mutant proteins are represented by the following 
symbols: WT+Ile, (   ); WT+Ile+tRNA, (   ); D399A+Ile, (   ); and D399A+Ile+tRNA, (   ).  
Error bars are based on the results of three reactions each and indicated for each point.  
42 
 
III.4 Discussion 
Representative of all LeuRSs, the hscLeuRS contains specific active sites for 
aminoacylation and editing that are located in separate domains.  X-ray crystal structures for 
LeuRSs from all three kingdoms (Fukunaga and Yokoyama 2005; Liu et al. 2006; Seiradake et 
al. 2009) have shown that within the CP1 editing domain, the LeuRS editing active site is 
marked by a threonine-rich peptide.  In the human enzymes, it includes the highly conserved 
Thr 298 specificity determinant (Thr 252 in E. coli LeuRS) as well as Thr 293 (Thr 247 in        
E. coli LeuRS) that has been shown to be important in orientating the editing substrate in the 
editing active site for catalysis by LeuRS (Zhai and Martinis 2005).  It also has the “GTG 
adenine-binding region” as well as a universally conserved aspartic acid that interacts with the 
amino group of the bound amino acid (Lincecum et al. 2003).  However, four peripheral peptide 
insertions distinguish the hscLeuRS and other eukaryotic CP1 domains from their bacterial 
counterparts. X-ray crystallography structures for the hscLeuRS and yeast cytoplasmic LeuRS 
show that although the integrity of the editing core is clearly maintained, these peripheral 
insertions appear to induce some local structural rearrangements (Seiradake et al. 2009). 
The I4 peptide insertion in the LeuRS CP1 domain is hypothesized to cap the editing 
active site when mischarged tRNA is bound (Seiradake et al. 2009).  Another insertion, called 
I2, contacts the bound editing substrate analogue.  In the yeast cytoplasmic LeuRS CP1 domain 
structure, the I2 insert also interacts with a network of water molecules.  It is possible then that 
displacement of these water molecules could provide some plasticity for the editing active site 
to facilitate an induced fit mechanism.  In the case of our results, water molecules could be 
displaced by the introduction of the bulky tyrosine residue at the Thr 298 specificity site in the 
hscLeuRS CP1 domain.  Based on the structure of the hscLeuRS CP1 domain, we hypothesize 
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that the tyrosine residue could flip into vacant space over the neighboring Val 479             
(Figure III.2) to allow binding of the editing substrate.  Indeed, closure of the I4 lid might 
facilitate an induced fit mechanism for the hscLeuRS editing site that adequately includes the 
bulky Tyr 298 mutation. 
The universal aspartic acid in the editing active site of the hscLeuRS is critical to tRNA 
deacylation as found for all other enzymes where it has been tested.  Here, we demonstrated that 
an alanine substitution at the conserved site blocks deacylation activity in vitro.  This is 
consistent with in vivo experiments showing that the introduction of a bulky positively charged 
lysine residue for the aspartic acid failed to protect yeast knock out cells from high 
concentrations of norvaline (Yao et al. 2008).   
Surprisingly, the universally conserved aspartic acid in the CP1 domain was not only 
important to editing active site substrate interactions, but also interactions with the amino acid 
in the synthetic active site.  Substitution of the aspartic acid resulted in a long distance KM effect 
on the amino acid activation step, which would be expected to be governed primarily by the 
aminoacylation active site in the canonical core.  Significantly, this long distance effect was 
selective for the cognate leucine amino acid suggesting that the CP1 domain might also distally 
influence amino acid discrimination within the aminoacylation core.   
Since aminoacylation activity is also decreased for the D399A hscLeuRS mutant, it is 
possible that tRNA mediates this distal amino acid discrimination effect in the synthetic site.  In 
this case, tRNA would be expected to bind in the so-called “exit/entry” position where its 3’ end 
is near the editing active site (Rock et al. 2007; Hellmann and Martinis 2009).  Translocation of 
the tRNA could be slowed as it sweeps through the altered editing active site enroute to the 
aminoacylation active site.  However, these long-distance effects were also detected in the 
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absence of tRNA during pyrophosphate exchange assays.  Thus, subtle changes in the editing 
active site must be transmitted via nodes within the protein itself to influence amino acid 
activation (Sethi et al. 2009).     
The D399A hscLeuRS mutant only exhibited weak mischarging activity relative to other 
corresponding LeuRS, IleRS, and ValRS mutants, where post-transfer editing activity was 
completely abolished.  Since the kinetic parameters for isoleucine activation were similar to the 
wild type and mutant LeuRS, we hypothesize that the tRNA plays a significant role in 
maintaining fidelity.  Indeed, mischarging activity seemed particularly sensitive to the presence 
of tRNA modifications and the origin of the tRNA.  Ironically, E. coli crude tRNA yielded 
greater levels of mischarged tRNA.  However, this could be because the E. coli tRNA was 
missing important elements that were embodied in the mammalian calf liver tRNA, which 
minimized mischarging of isoleucine by LeuRS.  If this were the case, we hypothesize that the 
human enzyme relies, at least in part, on pre-transfer editing that originates from the 
aminoacylation active site.  A redundant mechanism for amino acid editing that originates in the 
aminoacylation active site would allow fidelity to be rescued in the absence of post-transfer 
editing activity in the CP1 domain.  
The hscLeuRS is part of a large macromolecular complex that includes nine aaRSs and 
three small auxiliary proteins (Han et al. 2003; Kaminska et al. 2009).  A variety of approaches, 
such as electron microscopy, three-dimensional reconstruction (Wolfe et al. 2005), and tandem 
affinity purification (Kaminska et al. 2009) have been used to study the assembly of this 
macromolecular complex.  Cryo-EM was used to elucidate the structure of the multi-aaRS 
complex at 30 Å.  The imaging showed that this large complex is approximately                       
19 x 16 x 10 nm (Norcum and Warrington 1998; Norcum and Boisset 2002).  Although the    
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3.25 Å X-ray crystal structure of the human cytoplasmic LeuRS CP1 domain has also been 
solved (Seiradake et al. 2009), it is unclear how this editing domain and the remainder of the 
human LeuRS fit into the macromolecular complex.  In the context of the multi-aaRS complex, 
it is possible that domain motions such as the CP1 domain might be constrained.  In this case, 
redundant fidelity pathways may also serve as a more efficient amino acid editing mechanism 
that doesn’t require translocation of the mischarged tRNA to another editing domain.  Recently, 
we showed that in the absence of the CP1 domain for E. coli and yeast mitochondrial LeuRS, 
the enzyme maintained fidelity by targeting the activated adenylate intermediate            
(Boniecki et al. 2008).  In this case, isoleucyl-adenylate could be hydrolyzed within the 
aminoacylation active site (Gruic-Sovulj et al. 2005) or selectively released for hydrolysis in the 
cellular milieu (Hati et al. 2006).  Redundant mechanisms in amino acid editing could be 
essential to maintain a level of protein synthesis fidelity, particularly in mammals that would 
guard against neurological disease (Lee et al. 2006).    
We hypothesize that some of the architectural and mechanistic differences that are 
specific to hscLeuRS may have been acquired in part because of its association with the multi-
aaRS complex.  These differences have likely facilitated discovery of a novel class of 
benzoxaborole anti-fungal compounds, which are in development for the treatment of 
onchomycosis.  In particular, AN3018 inhibits yeast cytoplasmic LeuRS by forming a covalent 
adduct with the 3’ adenosine of the tRNALeu to trap it in the editing site (Rock et al. 2007).  
Significantly though, complementation experiments using yeast knock-out tester strains have 
indicated that the hscLeuRS is susceptible to AN2690 (Yao et al. 2008).  Furthermore, the 
D399K hscLeuRS editing-deficient mutant is resistant to AN2690 in complemented yeast cells 
(Yao et al. 2008), indicating the importance of the Asp 399 residue in hscLeuRS for binding 
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within the editing site.  The AN2690 inhibitor appears to bind to the human enzyme in these 
yeast complementation assays, in spite of crystal structure analysis of the hscLeuRS CP1 
domain that suggests that the size of the hydrophobic editing pocket is smaller than that of the 
yeast enzyme (Seiradake et al. 2009).  Nevertheless, a network of water molecules and an 
induced fit mechanism in the editing site could provide plasticity, especially in a version of 
hscLeuRS that is freed from its multi-aaRS macromolecular complex.  It is also important to 
note that native residence within the multi-aaRS macromolecular complex might hinder 
inhibitor interactions with the hscLeuRS CP1 domain, particularly in a mechanism that requires 
cross-linking the large tRNA substrate that spans two protein domains. 
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Chapter IV. Formation of bis-Aminoacylated tRNA with Human Cytoplasmic LeuRS 
 
IV.1. Introduction 
 
The E. coli LeuRS charges tRNA with a single leucine via an aminoacylation reaction.  
Leucine is first activated with ATP by LeuRS to form an aminoacyl-adenylate intermediate with 
the release of PPi.  In the second step, this activated leucine is charged to the 2’ ribose hydroxyl 
of the 3’ end of its cognate tRNA (Ibba and Söll 2004; Mascarenhas et al. 2008), as is the case 
with class I aaRSs. 
                                   ATP + Leucine  Leucine-AMP + PPi                                      (IV.1) 
 
                   Leucine-AMP + tRNALeu → Leucine-tRNALeu + AMP                             (IV.2) 
 
This correctly charged tRNA is handed off to EF-Tu to be brought to the ribosome for 
participation in translation.  Once the tRNA has successfully delivered the amino acid to the 
growing polypeptide chain in the ribosome, the tRNA is released and then binds LeuRS again 
for re-charging.  
Interestingly, it has been shown that T. thermophilus PheRS can attach two molecules of 
phenylalanine to tRNAPhe to form a bis-aminoacylated species (Figure IV.1)                   
(Stepanov et al. 1992).  One amino acid is located on the 2’ hydroxyl and the other is on the 3’ 
hydroxyl group of the 3’ adenosine of tRNA.  This bis-phenylalanylated-tRNA can actually 
participate in protein synthesis (Wang et al. 2006).  It binds the aminoacyl-site of the ribosome 
and contributes an amino acid from its 3’ -OH group on the 3’ adenosine of tRNA.  The donor 
tRNA can then dissociate from the ribosome as a monoacylated tRNA and continues on to 
participate in another round of translation in the ribosome (Wang et al. 2006).    
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Figure IV.1 Structure of bis-aminoacylated adenosine at the 3’ end of tRNA.  The 3’ adenosine 
of tRNA is bis-aminoacyated with two phenylalanines, one on the 2’ -OH and the other on the 
3’ -OH.  
 
The hscLeuRS enzyme displayed an interesting phenomenon during tRNA deacylation 
assays that I conducted to test post-transfer editing activity.  I typically observe hydrolysis of 
charged and mischarged tRNA during deacylation assays (Pang and Martinis 2009).  However, 
unlike the E. coli LeuRS, there was a subsequent re-accumulation of charged and mischarged 
tRNA with hscLeuRS.  This recharging occurrence was unexpected since ATP was not one of 
the components of the hydrolysis assay.  Great efforts were also made to ensure that there 
weren’t any lingering ATP contaminants in the reactions.  Based on previous findings regarding 
tandemly activated tRNAs (Stepanov et al. 1992; Wang et al. 2006), I wondered if the tRNA 
might be charged with two leucines at the terminal ribose of tRNA.  I postulated that the 
additional amino acid that is freed during the initial hydrolysis of charged and mischarged 
tRNA might be re-attached to a new incoming tRNA.  I then hypothesized that a dipeptide 
might be forming on the 3’ adenosine of tRNA. 
In order to test our hypothesis, I carried out a series of experiments to confirm the 
presence of two leucines charged on the tRNA.  Acidic gel electrophoresis to stably separate the 
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charged tRNA confirmed the initial decrease and subsequent regeneration of charged tRNA.  
Hydrolysis assays followed by nuclease digestion at various time points were carried out and I 
attempted to determine the chemical nature of the species charged to the tRNA via various 
techniques including TLC and liquid chromatography/mass spectrometry (LC/MS). 
IV.2. Experimental Procedures 
 
IV.2.1 Purification of hscLeuRS 
 
 The hscLeuRS was first purified via a HIS-Select HF Nickel affinity column as 
described in Chapter II.  This was followed by anion exchange chromatography using a mono 
QTM 5/50 GL column (Amersham Pharmacia Biotech, Piscataway, NJ) on the ÄKTA Purifier 
Fast Protein Liquid Chromatography (FPLC) system (GE Healthcare, Piscataway, NJ) using a 
continuous NaCl gradient that was applied for 20 column volumes to elute hscLeuRS.  The 
purified protein was dialyzed into 50% glycerol, 100 mM KPi, pH 6.8, 10 mM                           
β-mercaptoethanol buffer and stored at -20 °C.   
IV.2.2 Isolation of mono- and bis-Aminoacylated tRNA Samples for Analysis 
 
 Radioactive charged tRNA was enzymatically synthesized as described in Chapter II.  
Non-radiolabeled tRNA was necessary as radioactive samples were prohibited from being 
purified over the LC/MS.  The non-radioactive charged tRNA was also prepared as described in 
Chapter II, except 40 µM of transcribed E. coli tRNA and 80 µM of unlabeled leucine or 
isoleucine were substituted for 8 µM of transcribed E. coli tRNA and 22 µM [3H]-leucine or 
isoleucine.  A deacylation assay was conducted as described in Chapter II and aliquots were 
taken at 0, 5, and 10 min time points, followed by quenching in 400 mM sodium acetate, pH 5.0 
and 0.1% sodium dodecyl sulfate (SDS).   
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 Aliquots from deacylation assays were analyzed on an acidic gel (Varshney et al. 1991).  
The (mis)charged tRNA used for the deacylation assays was prepared as described in Chapter II 
except 1.2 mM of [14C]-leucine or [14C]-isoleucine (318 mCi/mmol) was used instead of 22 µM 
[3H]-leucine or [3H]-isoleucine.  Quenched aliquots of 20 µL volume from deacylation assays 
were loaded onto a 10 % acidic polyacrylamide gel that had been pre-equilibrated in 25 mM 
NaOAc, pH 5.0 (Varshney et al. 1991).  The gel was electrophoresed at 8 mA for approximately 
12 h overnight.  The gel was dried and phosphorimaged using a FUJI BAS 1000 phosphorimage 
screen (FUJI-FILM Medical Systems U.S.A., Stanford, CT) and quantified with a Storm 840 
Molecular Dynamics Imager (GE Healthcare, Piscataway, NJ). 
IV.2.3. Acetylation of Charged tRNA 
 The quenched aliquots from deacylation reactions were added to 50 µL of 5 mM sodium 
acetate pH 5.5, 10 µL of dimethyl sulfoxide, 20 µL of glacial acetic acid, and finally 20 µL of 
acetic anhydride.  The reactions were incubated on ice for 1 h before being ethanol precipitated 
(De Pereda et al. 2004).  Some samples were cleaved overnight with 5 units of P1 nuclease      
(Sigma, St. Louis, MO) at 37 ºC after acetylation and then ethanol precipitated the next day. 
IV.2.4 Separation of tRNA Samples using TLC 
Before separation by TLC, aliquots from deacylation reactions were subjected to either 
digestion with 0.1 µg/mL of RNase A or base hydrolysis with 0.5 M potassium hydroxide for     
2 h at 37 ºC.  The samples were spotted on a Whatman 60 Å silica gel TLC plate                             
(GE Healthcare, Piscataway, NJ) and developed in a mobile phase containing 
chloroform/methanol/32 % acetic acid (5:3:1) (Larkin et al. 2002).  After TLC separation, the 
plates were sprayed with ninhydrin and left to dry in an 80 ºC oven for 20 min in order to detect 
the leucine standards.  These standards were then spotted with 14C-leucine on the plate in order 
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to mark their positions.  The plate was phosphorimaged using a FUJI BAS 1000 phosphorimage 
screen (FUJI-FILM Medical Systems U.S.A., Stanford, CT) and quantified with a Storm 840 
molecular dynamics imager (GE Healthcare, Piscataway, NJ).  In an effort to identify some of 
the spots on the plate, the spots were scrapped and soaked in methanol to remove the running 
buffer.  They were then rocked in 4 M NH4OH for 30 min at room temperature and left 
overnight at room temperature to evaporate to dryness.  
IV.2.5 LC/MS of Aminoacylated Samples of tRNA 
The pelleted tRNA samples that had been cleaved with P1 nuclease were dissolved in 
water and analyzed on a 6300 Series Ion Trap LC/MS (Agilent Technologies, Foster City, CA),  
using a 100 mm x 4.6 mm PGC Thermo Hypercarb column (Thermo Fischer, Waltham, MA).  
The sample was separated on the PGC Hypercarb column using 25 mM ammonium acetate as 
the aqueous phase (A) and acetonitrile as the organic mobile phase (B) on the HPLC. The 
sample was purified using a linear gradient that began at time zero with 5 % of B.  The linear 
gradient increased from 5 % to 80 % B in 10 min, and then increased to 100 % B in the next      
5 min.  Finally, 100 % B was used to elute sample between 15-30 min.  After HPLC 
purification, the sample was run through the 6300 Series Ion Trap MS equipped with an 
electrospray ionization (ESI) interface that was run in both the positive as well as negative 
mode.  The experiments were conducted using a full-scan mode with a mass range m/z of       
100-700.  Alternatively, some samples were directly injected into a Micromas Q-TOF Ultima 
mass spectrometer (Waters Corporation, Milford, MA) to be analyzed.  
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IV.3. Results 
 
IV.3.1. Initial Hydrolysis Followed by Re-charging of tRNA by hscLeuRS 
 
The hscLeuRS enzyme was tested for post-transfer editing and displayed an 
unanticipated phenomenon.  In the presence of hscLeuRS, I observed that after the usual 
decrease in charged and mischarged tRNA, there was a subsequent re-accumulation of charged 
and mischarged tRNA during the deacylation assays (Figure IV.2).  
 
Figure IV.2 Recharging by wild-type and mutant hscLeuRS during deacylation reactions.  
Deacylation reactions were carried out with 1 µM enzyme and either A. ~4 µM E. coli           
Leu-tRNALeu or B. ~4 µM E. coli Ile-tRNALeu.  All enzyme reactions were incubated at 30 °C.  
The hscLeuRS protein is represented by (   ) and mutant protein T298A by (   ). 
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Based on previous findings regarding tandemly activated tRNAs (Stepanov et al. 1992;       
Wang et al. 2006), I hypothesized that the tRNA might be charged with two leucines at the 
terminal ribose of tRNA.  This recharging effect was surprising since ATP, which is typically 
required to charge tRNA, was not one of the components of the deacylation assays. I then 
hypothesized that the additional amino acid that is freed during the initial hydrolysis of charged 
and mischarged tRNA might be re-attached to a new incoming tRNA, possibly generating a 
dipeptide on the tRNA. 
Steps were taken to ensure that the reaction was free of ATP.  The hscLeuRS was 
purified as described in Chapter II in addition to a second round of purification over an anion 
exchange column using a FPLC system.  This was done to ensure that hscLeuRS was free of 
any small molecule contaminants such as ATP.  In addition, a control aminoacylation assay was 
carried out with purified hscLeuRS and leucine in the absence of externally added ATP.  This 
control assay showed no charging activity, further confirming the absence of an ATP 
contaminant on hscLeuRS (Figure IV.3).  
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Figure IV.3 The hscLeuRS is unable to charge tRNA without the addition of ATP.  
Aminoacylation reactions contained 4 µM tRNALeu, 20 µM leucine, 500 nM enzyme, and either 
no ATP or 4 mM ATP. The hscLeuRS with 4 mM ATP and no additionally added ATP is 
represented by (   ) and (    ) respectively. 
 
In addition, acidic gel electrophoresis was employed to stably separate charged tRNAs 
in order to confirm the initial decrease and subsequent regeneration of charged tRNA.  I focused 
mainly on using the hscT298A mutant that hydrolyzes correctly charged Leu-tRNALeu          
(Pang and Martinis 2009).  Aliquots were taken at various time points during the course of the 
deacylation assay and separated on an acidic gel as described before.  Analysis of the acidic gels 
revealed a reaccumulation of charged tRNA with T298A (Figure IV.4).  Separating the charged 
tRNA samples on an acidic gel also helped confirm that free amino acid released during the 
deacylation wasn’t sticking non-specifically to hscLeuRS, resulting in an erroneously high 
reading during deacylation assays.  
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Figure IV.4 Reaccumulation of charged tRNA based on acid gel analysis.  Deacylation 
reactions were carried out at 30 °C with 1 µM E. coli T252A or hscT298A, and ~4 µM E. coli 
Leu-tRNALeu.  Aliquots taken at 0, 3, 6, and 10 min time points during deacylation were 
separated on a 10 % acid gel.  The acid gel was electrophoresed dried and phosphorimaged 
using a FUJI BAS 1000 phosphorimage screen.  The intensities of the bands appearing on the 
acid gel (A) were quantified with a Storm 840 Molecular Dynamics imager and plotted (B). The 
hscLeuRS T298A mutant is represented by (   ), E. coli T252A by (    ) and no enzyme by (   ). 
 
Finally, I tested the viability of my hypothesis by conducting a PPi exchange assay as 
described in Chapter II in order to determine if hscLeuRS activates dipeptidyl leucine-leucine.  
Interestingly, unlike E. coli LeuRS, hscLeuRS activates dipeptidyl leucine-leucine            
(Figure IV.5).  The hscLeuRS was unable to activate tri-peptidyl leucine-leucine-leucine. 
 
A. 
B. 
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Figure IV.5 The hscLeuRS enzyme activates both leucine and dipeptidyl leucine-leucine.  Spots 
representing ATP were visualized on TLC plates indicating activation of amino acid.  Aliquots 
were quenched at 0, 15, 30, 45, and 60 minute time points. The presence of ATP spots on the 
first two plates indicates that Leu and Leu-Leu are activated by hscLeuRS.  The absence of ATP 
spots on the right most plate indicates that tripeptidyl Leu-Leu-Leu is not activated in the first 
step of aminoacylation.  
 
IV.3.2 Analysis by TLC Could Not Confirm Presence of bis-Aminoacylated tRNA Species 
 
 I reasoned that if a dipeptide was indeed forming on the 3’ adenosine of tRNA, then 
cleaving the tRNA into individual nucleotides would yield a modified adenosine corresponding 
to the 3’ adenosine with a dipeptide on it.  I used RNase A to digest the quenched aliquots from 
deacylation assays in order to yield the free 3’ adenosine that had a radiolabeled amino acid 
charged on it.  The digested samples were separated on a TLC plate as described above.  I 
predicted that the modified adenosine would have a distinct shift on the TLC plate as compared 
to adenosine charged with just one leucine.  In another set of experiments, I also treated aliquots 
from the deacylation assays with base in order to hydrolyze the amino acid from the 3’ 
adenosine.  These samples were separated using TLC that also had free leucine and leucine-
leucine dipeptides as standards.  I observed a shift in spots with samples taken from the 4 min 
and 10 min time points that were digested with RNase A.  These spots were scrapped and 
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quantified by ESI mass spectrometry.  Unfortunately, the mass spectrometric data was 
inconclusive as I was unable to identify the origins of the spot that had shifted from the 
standards (Figure IV.6).  I reasoned that the aminoacyl adenylate might be unstable and subject 
to hydrolysis within minutes as previously reported (Duca et al. 2008).  Hence, I refined my 
strategy to stabilize the charged substrates by acetylating the aminoacylated tRNA samples in 
order to protect its free amine group.  I then proceeded to use LC/MS to identify tRNA samples 
that were pre-acetylated (De Pereda et al. 2004).    
 
 
Figure IV.6 Samples separated via TLC did not reveal a dipeptidyl-adenosine species.  Aliquots 
of tRNA samples obtained from various time points throughout the deacylation assay were 
subjected to either RNase A or base hydrolysis.  Boxed in red are 2 unidentifiable spots 
appearing from RNase A digestions of aliquots obtained at time 4 and 10 min during 
deacylation of charged tRNA with hscT298A. “0R” represents RNase A digestion of aliquots 
taken at the 0 min time point during deacylation, “0B” represents base hydrolysis of aliquots 
taken at the 0 min time point during deacylation, “4R” represents RNase A digestion of aliquots 
taken at the 4 min time point during deacylation, “4B” represents base hydrolysis of aliquots 
taken at the 4 min time point during deacylation, and so forth.  
 
IV.3.3. Liquid Chromatographic and Mass Spectrometric Analysis Could Not Confirm  
Presence of bis-Aminoacylated tRNA Species 
 
Since the separation of samples with TLC was inconclusive, I then directly purified the 
hypothesized dipeptidyl samples from the deacylation assays over a LC/MS.  Deacylation 
assays were conducted and aliquots collected at 0, 5, and 10 min time points.  These aliquots 
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were quenched and acetylated as described above.  After acetylation, the samples were then 
digested overnight with 5 units of P1 nuclease at 37 °C before ethanol precipitation.  Just before 
purification over the LC/MS, the pelleted samples were resuspended in water.  I was very 
fortunate to have also received a chemically synthesized AMP-leucine-leucine compound from 
Dr. Sidney Hecht’s group at Arizona State University that would function as a standard for the 
modified adenosine with two leucines on it.   
Analysis via the 6300 Series Ion Trap LC/MS was unsuccessful as the instrument was 
not sensitive enough to detect samples present in picomole amounts.  Subsequently, I injected 
the samples directly on a Micromas Q-TOF Ultima mass spectrometer                                       
(Waters Corporation, Milford, MA), which provided higher levels of sensitivity.  The Q-TOF 
enabled me to conduct high resolution ESI MS on the samples.  The AMP-leucine-leucine 
standard as well as a P1 nuclease cleaved tRNA sample were injected into the Q-TOF as 
controls.  A good mass spectra was obtained with these controls in the Q-TOF and I attained a 
distinct peak indicating the presence of AMP (m/z 348.1) from my cleaved tRNA sample as 
well as one indicating the presence of AMP-leucine-leucine  (m/z 574.2) (Figure IV.7).  
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Figure IV.7 Spectra from Q-TOF indicating the presence of the controls.  A. The peak at           
m/z 348.1 represents AMP from tRNALeu liberated by P1 nuclease.  B. Spectra from synthesized 
AMP-leucine-leucine standard. The peak at m/z 574.2 represents AMP-leucine-leucine.  
Samples were run using ESI in the positive mode.  
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Unfortunately, all other leucylated tRNA samples obtained from deacylation assays were not 
detected on both the LC/MS and Q-TOF, in spite of the extra stability conferred by acetylating 
the charged tRNA samples possibly due to their low concentrations.   
IV.4.  Discussion 
 
The unanticipated phenomenon displayed by hscLeuRS during deacylation assays, 
whereby there was an initial dip followed by a reaccumulation of charged products            
(Figure IV.2), led me to hypothesize that the hscLeuRS might be charging two leucines on the 
3’ adenosine of tRNA.  It has been reported previously that T. thermophilus PheRS can form 
bis-aminoacylated tRNAPhe with 2 phenylalanines, one on the 2’ -OH and another on the 3’ -OH 
of the 3’ adenosine of tRNA (Stepanov et al. 1992) (Figure IV.2).  However, it did not seem 
plausible that I was synthesizing a bis-leucylated species since there was no ATP in the reaction 
to facilitate the charging of amino acid on tRNA.  The hscLeuRS was purified over a series of 
two columns to remove any small molecule contaminants and control aminoacylation 
experiments conducted with purified hscLeuRS and leucine in the absence of externally added 
ATP did not yield any charged product.  Instead, I hypothesized that a dipeptide could be 
forming on the 3’ adenosine when a free amino acid forms a peptide bond with an amino acid 
on an existing charged tRNA species.  The PPi exchange assays that I conducted indicated that 
hscLeuRS, unlike the E. coli LeuRS, activates leucine-leucine, thus supporting my dipeptidyl 
tRNA formation hypothesis.   
Paradoxically, Dr. Sidney Hecht’s group has shown that in contrast to the                       
bis-aminoacylated species, the dipeptidyl species is unable to participate in protein synthesis 
(Wang et al. 2006).  Based on the many published articles on the alternate functions of aaRSs, it 
seemed plausible that the hscLeuRS was creating a dipeptidyl tRNA to help serve some of its 
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other purposes within the cell (Martinis and Pang 2007).  Interestingly, some groups have 
shown that multiple peptide resistance virulence factors (mprF) can use Lys-tRNALys to modify 
phosphatidylglycerol although it is still unclear as to how Lys-tRNALys bound by EF-Tu is first 
sequestered by mprF (Peschel et al. 2001; Thedieck et al. 2006; Roy and Ibba 2008).  This      
Lys-tRNALys can then aminoacylate inner membrane lipids resulting in a change in cellular 
permeability to certain cationic antibiotics (Roy and Ibba 2008).  Additionally, aminoacylated 
tRNAs can participate in a host of other functions including cell wall and porphyrin 
biosynthesis (Ibba and Söll 2004).  It is thus possible that a dileucyl-tRNALeu might participate 
in similar functions, although it should be noted that new alternate functions of aaRSs are 
continuously being discovered, and it is difficult to say for sure what other functions a    
dileucyl-tRNALeu might serve.  
Acidic gels were also used to confirm the increase in charged tRNA during the course of 
our deacylation assays.  In order to isolate our hypothesized dipeptidyl-tRNA, a series of 
deacylation assays were conducted and aliquots were taken at various time points to be analyzed 
for possible dipeptidyl-tRNA.  The isolated tRNA was cleaved with either RNase A or P1 
nuclease and I attempted to identify a modified adenosine that would have two leucines on it.  
Various methods were employed, including the analysis of samples by TLC, LC/MS, as well as 
Q-TOF MS.  
Separation via TLC proved inefficient as I did not observe a distinct upward shift in 
spots representing a di-charged species.  The lack of a radiolabeled adenosine-leucine-leucine 
further complicated the experiment and TLC also failed to achieve high enough sensitivity in 
order to detect picomole quantities of product.  I was further unsuccessful in trying to isolate the 
dipeptidyl species via MS from scrapped samples on the TLC plate.  I later realized that an 
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adenosine aminoacylated with leucine(s) would be fairly unstable and that it would be necessary 
to acetylate the leucines attached to the adenosine in order to protect the free amino groups on 
leucine (Duca et al. 2008).  However, in spite of acetylating the samples, LC/MS as well as       
Q-TOF MS continued to be unproductive in isolating the dipeptidyl species.  
The elusiveness of this dipeptidyl-tRNA sample might be attributed to the very low 
quantities that it is produced during the reaction.  We began with 4 µM of Leu-tRNALeu during 
deacylation assays, resulting in a very low concentration of isolated tRNA sample.  The initial 
concentration of charged tRNA species used in the deacylation assays was increased by 10-fold 
to 40 µM.  However, attempts to isolate the dipeptidyl species continued to be unsuccessful.  In 
addition, aminoacylated adenosyl sample is unstable and degrades over time, further lowering 
the detectable amount of dipeptidyl species left in the sample.  One possibility of improving the 
yields of tRNA is to run full length acetylated tRNA products from the deacylation assays in 
order to reduce degradation and sample loss during the steps that are required to digest tRNA 
into individual nucleotides.  This way, there will be a higher chance of isolating the elusive 
dipeptidyl species.   
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Chapter V. Characterization of Protein-Protein Interactions Between the CP1 Domain 
and Canonical Aminoacylation Core   
 
V.1 Introduction 
The aminoacylation site of aaRSs activates cognate amino acid as well as isosteric non-
cognate amino acids (Hendrickson and Schimmel 2002; Mascarenhas et al. 2008).  Misactivated 
amino acids could then be mistakenly charged on to tRNAs, resulting in mischarged tRNA.  In 
order to maintain fidelity, some aaRSs such as LeuRS, IleRS and ValRS have an editing module 
termed the CP1 domain (Starzyk et al. 1987; O'Donoghue and Luthey-Schulten 2003) that binds 
incorrectly charged tRNAs and cleaves them (Lin et al. 1996).  This prevents the mischarged 
species from being brought to the ribosome for participation in protein synthesis.   
The CP1 domain is connected to the canonical core via two β-strands                     
(Cusack et al. 2000) and its hydrolytic editing active site is separated from the aminoacylation 
site by approximately 30 Å.  Based on the comparison of several crystal structures    
(Mascarenhas et al. 2008), the CP1 domain adopts different conformational states relative to the 
canonical core.  This likely accommodates the various stages of tRNA binding, and is 
dependent on the rotational flexibility of the CP1 domain and also the dynamic nature of the β-
strands (Mascarenhas and Martinis 2008; Mascarenhas and Martinis 2009).  
When tRNA is bound to LeuRS, the CP1 domain rotates ~30° relative to its apo state 
during translocation (Tukalo et al. 2005).  It has been hypothesized that this movement 
facilitates translocation of tRNA from the catalytic core domain to the CP1 domain for editing           
(Tukalo et al. 2005).  During this process, the canonical core and CP1 domain have been 
proposed to interact via putative transient protein-protein interactions (Figure V.1)          
(Williams and Martinis 2006).  Specifically, salt bridges were hypothesized to form between 
specific residues across the interface of the canonical core as well as CP1 domain in order to 
64 
 
allow crosstalk between both modules.  These inter-domain interactions are thought to be 
especially essential when post-transfer editing is disrupted in E. coli LeuRS, and the cell is 
forced to rely on pre-transfer editing to ensure overall fidelity.  It is possible this redundant or 
secondary pre-transfer editing mechanism relies on the formation of these transient salt bridges 
between the catalytic core domain and the CP1 domain.  Upon activation, pre-transfer editing 
facilitates the hydrolysis of aminoacyl-adenylate intermediates (Williams and Martinis 2006).  
In addition, more recent work has shown that a “translocation peptide” located within 
the vicinity of an Asp 391 hinge in E. coli LeuRS, is essential for the translocation of tRNA       
(Figure V.1) (Hellmann and Martinis 2009).  The theoretically predicted Asp 391 hinge is 
hypothesized to confer flexibility that directs rotation of the CP1 domain relative to the main 
body.  Mutations within this translocation peptide have resulted in amino acid toxicities owing 
to the bypassing of the editing domain by mischarged tRNA species                              
(Hellmann and Martinis 2009).  Translocation is essential for accurate charging of the tRNA.  
However structural analysis of this process has proven to be difficult due to its transient nature.  
Hence, we proposed to study the interactions between the canonical core and CP1 domain via 
biophysical techniques in order to elucidate the translocation process.  
Herein, I characterized macromolecular protein-protein interactions between the CP1 
editing domain and the aminoacylation core that might be important to translocation.  A 
deletion mutant of E. coli LeuRS (LeuRS-ΔCP1) that lacks the entire CP1 domain (including 
both β-strands that link the CP1 domain to the core) (Boniecki et al. 2008) and constructs of the 
isolated LeuRS CP1 domain (Betha et al. 2007) (Figure V.1).  Both these dissected domains are 
functional in their respective activities (Betha et al. 2007; Boniecki et al. 2008).  To help us 
better decipher the translocation of editing substrates from the main body to the CP1 domain, 
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we tested these isolated active LeuRS domains for protein-protein interactions using 
immunoprecipitation pull-down assays as well as smFRET. 
 
 
 
Figure V.1 Tertiary structures of E. coli LeuRS.  (A) Homology model of wild-type E. coli 
LeuRS (Lee and Briggs 2004) with the translocation peptide highlighted in yellow.  The 
residues Lys 186 and Ala 293 are depicted in ball and stick form in blue and are proposed to 
interact with each other (Williams and Martinis 2006).  (B) Homology model of isolated ΔCP1 
domain of      E. coli LeuRS (Boniecki et al. 2008) on the left and isolated CP1 domain on the 
right (Betha et al. 2007).  The canonical core domain is shaded in green while the CP1 domain 
is shaded in red. 
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V.2. Experimental Procedures 
V.2.1 Immunoprecipitation Assays 
 
Hemagglutinin (HA) and myc epitope tags were inserted on the his-tagged LeuRS-ΔCP1 
(Boniecki et al. 2008) and CP1 domains (Betha et al. 2007) respectively on their N-terminal 
ends.  Plasmid pBETeCP1-2-35 encodes the E. coli LeuRS CP1 domain from Val 216 to          
Ala 430.  A HA tag was cloned in at the N-terminus between the XbaI and NcoI restriction sites 
using the primers HA-Fwd (5'-CTA GAA TGA CCT ACC CAT ACG ACG TCC CAG ACT 
ACG CTC A-3') and HA-Rev (5'-CAT GTG AGC GTA GTC TGG GAC GTC GTA TGG GTA 
GGT CAT T-3') to give pJPCP1HA.  Subsequently, a myc tag was cloned in at the N-terminus 
of the canonical core domain between the XbaI and NcoI restriction sites using plasmid     
pMTV-ΔCP13a.  Primers Myc-Fwd (5'-CTA GAA TGA CCG AAC AAA AAC TTA TTT 
CTG AAG AAG ATC TGC A -3') and Myc-Rev (5'-CAT GTG CAG ATC TTC TTC AGA 
AAT AAG TTT TTG TTC GGT CAT T-3') to give pJPmbmyc. 
The LeuRS-ΔCP1-myc and LeuRS-CP1-HA were expressed and purified in a similar 
fashion as the untagged proteins.  Varying concentrations of the lysate or purified form of 
LeuRS-ΔCP1-myc was incubated with 50 µl anti-myc antibody beads (Pierce, Rockford, IL) in 
binding buffer (50 mM HEPES, pH 7.6, 30 mM KCl, 20 µM leucine, and 30 mM MgCl2) for     
1 h at 4°C.  The beads were washed three times with 1 ml of wash buffer (0.05% Triton X-100,     
10% glycerol, 50 mM NaCl, 50 mM HEPES, pH 7.5).  Varying concentrations of the lysates or 
purified forms of LeuRS-CP1-HA were then added for an overnight incubation at 4°C together 
with LeuRS-ΔCP1-myc immobilized to anti-myc antibody beads, in the absence or presence of 
E. coli transcribed tRNA.  The next day, the beads were washed three times again with 1 ml of 
wash buffer at room temperature and eluted with the elution buffer from a ProFound Co-IP kit  
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(Pierce, Rockford, IL).  Co-precipitation of LeuRS-ΔCP1 with CP1 was then detected by 
Western blotting using monoclonal anti-his antibodies (Sigma, St. Louis, MO).   
V.2.2 Western Blots 
 
 Proteins were separated on a sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) gel.  The gel was washed in Tris-Buffered Saline and Tween 20 (TBST) for         
5 min.  The proteins were then transferred by electrophoresis at 200 mA for 2 h in transfer 
buffer (25 mM Tris, pH 8.0, 250 mM glycine, 20% methanol) from the SDS-PAGE gel to a 
Protran BA85 nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany) that had been 
presoaked in TBST for 5 min.  The membrane was then removed and washed in TBST at room 
temperature for 10 min before blocking with 5% powdered milk at room temperature for 1 h.  
The membrane was incubated with a 1:1000 dilution of primary antibody in 5% milk TBST at 
room temperature for 1 h.  Following that, it was washed three times in TBST for 10 min each 
time before incubation with 5% milk TBST solution containing a 1:5000 dilution of secondary 
antibody.  Finally, the membrane was washed three times, 10 min each, at room temperature 
before being soaked in 0.56 mM 5-bromo-4-chloro-3-indolyl phosphate and 0.48 mM nitro blue 
tetrazolium (BCIP/NBT), 10 mM Tris-HCL, pH 9.2, and 59.3 mM MgCl2 premixed liquid 
substrate solution (Sigma, St. Louis, MO) for 2 min until dark bands appeared on the filter.  The 
reaction was quenched in water and air-dried.   
V.2.3 Fluorescent Labeling of E. coli LeuRS Using an Orthogonal System 
Plasmid pJPE317amber encodes the E. coli LeuRS E317amber mutant (harboring an 
amber stop codon at Glu 317) made using primers E317amber-Fwd (5'-CCA TTA ACG GGC 
GAA TAG ATT CCC GTT TGG GC-3') and E317amber-Rev (5'-GCC CAA ACG GGA ATC 
TAT TCG CCC GTT ATT GG-3').  The plasmid pSup_pAcPheRS_TRN                                
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(Ryu and Schultz 2006) was a gift from Dr. P. Schultz (The Scripps Research Institute; La Jolla, 
CA) and is a single-plasmid system that encodes multiple copies of an amber suppressor tRNA 
from Methanocaldococcus jannaschii as well as an orthogonal PheRS harboring a D286R 
mutation that allows p-acetyl-L-phenylalanine to be substituted at an amber stop codon.  E. coli 
BL21 (DE3) plysS (Novagen, Madison, WI) cells were transformed with pJPE317amber and 
pSup_pAcPheRS_TRN, and grown in LB containing 100 µg/ml of ampicillin, 34 µg/ml of 
chloramphenicol, and 1.0 mM p-acetyl-L-phenylalanine (RSP Amino Acid Analogues, 
Worchester, MA) at 37 °C, until the OD600 was between 0.4 and 0.6.  Protein expression was 
induced overnight at room temperature by the addition of 0.5 mM IPTG and later purified as 
described in Chapter II. 
V.2.4 Fluorescent Labeling of a Cysteine-knockout E. coli LeuRS Using Maleimide 
Chemistry 
 
 Plasmid pJP4cysko encodes the E. coli LeuRS with the mutations C37V, C128S, 
C505T, and C565T.  I began with plasmid p15ec3-1 that encoded wild-type E. coli LeuRS and 
made base substitutions using PCR mutagenesis methods as described in Chapter II.  The C37V 
mutation was made first using primers C37V-Fwd (5'-GAG AAG TAT TAC GTC CTG TCT 
ATG CTT-3') and C37V-Rev (5'-GAA GCA TAG ACA GGA CGT AAT ACT TCT C -3') to 
give plasmid pJPC37V.  The plasmid pJPC37V was used to insert the C128S mutation using 
primers C128S-Fwd (5'-GAG CTG GCA ACC AGT ACG CCG GAA TAC-3') and C128S-Rev 
(5'-GTA TTC CGG CGT ACT GGT TGC CAG CTC-3') to give plasmid pJP2_cys.  The 
plasmid pJP2_cys was used to insert the C505T mutation using primers C505S-Fwd (5'-GCG 
CGC TAC ACT AGC CCG CAG TAC AAA-3') and C505S-Rev (5'-TTT GTA CTG CGG 
GCT AGT GTA GCG CGC-3') to give plasmid pJP3_cys.  Finally, the plasmid pJP3_cys was 
used to insert the C565T mutation using primers C565T-Fwd (5'-GAA ACA GTT GCT GAC 
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TCA GGG TAT GGT G-3') and C565T-Rev (5'-CAC CAT ACC CTG AGT CAG CAA CTG 
TTT C-3') to give plasmid pJP4cysko.  The Glu 317 residue in pJP4cysko was substituted with 
a cysteine using primers E317C-Fwd (5'-CCA TTA ACG GGC GAA TGT ATT CCC GTT 
TGG-3') and E317C-Rev (5'-CCA AAC GGG AAT ACA TTC GCC CGT TAA TGG-3') to 
give pJP4cysko317C. 
 The protein was expressed from pJP4cysko317C in E. coli strain BL21 (DE3) codon 
PLUS cells (Stratagene, La Jolla, CA).  This protein was purified over a HIS-Select HF Nickel 
Affinity (Sigma, St, Louis, MO) resin as described in Chapter II.  The concentration of the 
protein calculated using an extinction coefficient of 166170 liters/mol·cm as computed by the 
ExPASy Protparam tool (http://ca.expasy.org/tools/protparam.html). 
 The protein was then diluted to 1 mg/ml in 500 µL phosphate buffered saline (PBS), 
flushed with nitrogen for 5 min and incubated at room temperature for 30 min.  The reducing 
agent tris(2-carboxyethyl)phosphine (TCEP) (Thermo Scientific, Rockford, IL) was added at a 
final concentration of 1 mM to the protein and incubated further at room temperature for 20 
min.  The cyanine-5 (cy5) maleimide monoreactive dye (GE Healthcare, Piscataway, NJ) was 
dissolved in 50 µL of dimethylformamide (DMF), flushed with nitrogen for 5 min, and 25 µL 
was added to the 500 µL protein solution.  The protein and dye solution together was again 
flushed with nitrogen and then incubated for 2 h in the dark.  The reaction was later quenched 
into 0.5% β-mercaptoethanol (BME) and the labeled protein was then purified over a PD-10 
desalt column (GE Healthcare, Piscataway, NJ).   
 The protein was further purified over a series of three HiTrapTM desalting columns    
(GE Healthcare, Piscataway, NJ).  The HiTrapTM columns were equilibrated in 70 mM Tris,     
pH 7.5, 350 mM NaCl, 1 mM DTT and the protein eluted in 20 mM Tris, 100 mM NaCl, and     
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1 mM DTT.  The labeled protein was concentrated in a Centricon-50 (Amicon, Bedford, MA) to 
approximately 100 µL.  The concentration of protein and dye was determined on the basis of its 
absorbance at 280 nm and 649 nm, and calculated using an extinction coefficient of            
166170 liters/mol·cm and 250000 liters/mol·cm respectively as computed by the ExPASy 
Protparam tool (http://ca.expasy.org/tools/protparam.html).  A correction factor of 0.05 for the 
cy5 dye was taken into consideration while reading the absorbance.  The following equations 
were used to compute the [Dye/Protein] ratio. 
[cy5 dye]=Absorbance649/250000                                                                                            [V.1] 
[LeuRS] = [Absorbance280 - (0.05 x Absorbance649)] / 166170                                               [V.2] 
[Dye/Protein]final = [dye] / [protein]                                                                                         [V.3] 
[Dye/Protein]final = [0.66 x Absorbance649]/[Absorbance280 - (0.05 x Absorbance649)]           [V.4] 
V.2.5 Splint Ligation of tRNA with Modified Base 
 Initial efforts to label the tRNA with a cyanine-3 (cy3) dye involved the splint ligation 
of two RNA fragments using T4 RNA ligase (Fermentas, Glen Burnie, MD).  The first RNA 
fragment (RNACGthy) consisted of a chemically synthesized fragment harboring a modified 
nucleotide 5-C6-Amino-2’-deoxythymidine (ChemGenes Corporation, Wilmington, MA).  This 
fragment, RNACGthy (5'-GC(5-C6-Amino-2’-deoxythymidine) CGG AUG GUG GAA UCG-
3'), was  used to conjugate an N-hydroxysuccinimide (NHS) derivative of a cyanine dye later on 
(Edwards and Sigurdsson 2005).  The second fragment (RNAtrans) consisted of a transcribed 
piece of tRNA (plasmid pJPtRNA3/4) that was ¾ of full length E. coli tRNALeu and had the 
sequence RNAtrans (5'-GUA GAC ACA AGG GAU UUA AAA UCC CUC GGC GUU CGC 
GUC GUG CGG GUU CAA GUC CCG CUC CGG GUA CCA-3').  The underlined regions in 
both fragments represent the nucleotides flanking the splint.  This ¾ length tRNA was 
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constructed via PCR deletion mutagenesis on ptDNALeu14 using primers pJPtRNA3/4-Fwd 
(5'-CTA ATA CGA CTC ACT ATA GTA GAC ACA AGG G-3') and pJPtRNA3/4-Rev (5'-
CCC TTG TGT CTA CTA TAG TGA GTC GTA TTA G-3').  A DNA splint (DNAsp) with 
sequence DNAsp (5'- GTG TCT ACC GAT TCC -3') was used to hold the two fragments of 
tRNA together to be ligated.  The ligations were carried out in a total volume of 10 µL with     
10 µM each of the two RNA fragments as well as 20 µM of DNA splint in buffer containing    
50 mM Tris(HCl), pH 7.4, 10 mM MgCl2. 5 mM ATP, and 5 mM DTT.  The RNAtrans was 
first phosphorylated at 30 °C with 15 units of T4-polynucleotide kinase (T4-PNK) (Fermentas,     
Glen Burnie, MD).  Both RNA samples were heated at 80 °C for 2 min and then cooled at room 
temperature for 30 min.  Ligation reactions were carried out for 3 h at 30 °C with 30 units of T4 
RNA ligase.  Finally, the DNA splint was digested with 5 units of DNase I (Sigma, St Louis, 
Mo) for 15 min at 30 °C.  In order to analyze the ligation reactions, 2 µL of each ligation 
reaction was loaded on a 10% urea-PAGE gel that contained 8 M urea.  The gel was analyzed 
for full length tRNA by visualizing with UV shadowing.  A faint band corresponding to full 
length tRNA was excised from the gel and eluted as described in Chapter II.  Unfortunately, less 
than 20 µM of full length tRNA in a 50 µL volume was extracted from the gel.  I then resorted 
to purchasing full length tRNALeu internally labeled with a cy3 dye from ChemGenes 
Corporation (Wilmington, MA) with the sequence RNAsynthesized (5'- GCC CGG AUG GUG 
GAA UCG GUA GAC ACA AG(cyanine-3)G GAU UUA AAA UCC CUC GGC GUU CGC 
GUC GUG CGG GUU CAA GUC CCG CUC CGG GUA CCA -3'). 
V.2.6 Preparation of PEGylated Quartz Slides 
 
 Silanized quartz slides were coated with polyethylene glycol (PEG)                         
(Nektar Therapeutics, San Carlos, CA) and 1-2% (wt/wt) of biotin-PEG                              
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(Laysan Bio. Inc., Arab, AL) and left to dry overnight.  Neutravidin                                   
(Thermo Scientific, Rockford, IL) was then used to coat the PEGylated slide at a final 
concentration of 0.2 mg/ml (Ha 2001), followed by 20 nM of biotinylated histidine antibody 
(Qiagen, Valencia, CA), which was specific for the histidine tag on the labeled protein.   
V.2.7 Single Molecule Data Acquisition and Analysis 
 
 All smFRET measurements were conducted with 10 nM cy5-LeuRS and 4 nM           
cy3-tRNA (ChemGenes, Wilmington, MA) at room temperature in a buffer containing 50 mM 
HEPES pH 7.6, 30 mM KCl, 30 mM MgCl2, 1 µM ATP and an oxygen scavenger system       
(0.1 mg/ml glucose oxidase (Sigma, St. Louis, MO), 0.02 mg/ml catalase (Hoffmann-La Roche, 
Basel, Switzerland), 1% BME (Sigma, St. Louis, MO), 0.4% (wt/wt) β-D-glucose (Sigma,       
St. Louis, MO) and trolox (Sigma, St. Louis, MO)) to reduce photobleaching and photoblinking 
events (Rasnik et al. 2006).  Data was collected using a wide field total internal reflection (TIR) 
fluorescence microscope.  Both a prism and an oil-immersion objective (Olympus UplanSApo 
100x numerical aperture 1.4) were used for TIR excitation.  An electron multiplying charged 
coupled device (CCD) camera, iXon DV 887-BI  (Andor Technology, South Windsor, CT) and 
an in-house C++ program were used to capture images at a 30 ms time resolution.  The setup 
was corrected for filter leakage and all FRET values were calculated as the ratio of the acceptor 
intensity divided by the sum of the intensities of the donor and acceptor fluorophore (Ha 2001).      
 All image files obtained were analyzed using IDL (ITT Visual Information Solutions, 
Boulder, Co) software and Matlab (The MathWorks, Natick, MA) (Roy et al. 2008).  Only time 
traces that contained a single photobleaching step for cy3 and cy5 were selected.  TIRF movies 
were obtained using in-house software.  The HaMMy program was used for Hidden Markov 
Modeling (HMM) analysis of the smFRET data (McKinney et al. 2006).   
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V.3. Results 
V.3.1 Potential Non-covalent Protein-protein Interactions Detected from Co-   
Immunoprecipitation of ΔCP1 and CP1 Domains 
 
A myc and HA tag was cloned to the E. coli LeuRS ΔCP1 and CP1 domains 
respectively at the N-terminus.  The proteins were expressed with their respective tags and                             
co-immunoprecipitation pull-down assays were conducted.  Antibodies that recognize one or 
the other epitope tag were used to detect the presence of protein-protein interactions between 
the two domains (Figure V.2).  
 
 
Figure V.2 Cartoon of immunoprecipitation pull-down assay.  The LeuRS-ΔCP1 and CP1 
domains were individually expressed and co-immunoprecipitation pull-down assays were 
conducted with them.  The canonical core domain is represented by a green square, the CP1 
domain by a blue circle, the myc- and HA-tags by gray rectangles, and the histidine-tag by a 
yellow rectangle.   
 
Co-precipitation of LeuRS-ΔCP1 with CP1 was then probed by Western blotting.  The pull-
down assays were conducted with purified protein as well as protein in lysate form.  
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Interestingly, co-immunoprecipitation pull-downs with purified proteins did not yield bands that 
might have been indicative of interaction between the two domains.  However, when lysates of 
the LeuRS-ΔCP1 with CP1 domain were used instead, the appearance of two bands representing 
both sub-domains suggested potential non-covalent protein-protein interactions (Figure V.3).  
We were intrigued by this and hypothesized that additional factors present in cell lysates were 
essential for interaction between the two domains to occur.   
Mutations within the ΔCP1 and CP1 domains were also made based on previous data 
from our lab regarding two residues, Lys 186 (within the canonical core domain) and Ala 293 
(within the CP1 domain).  These two sites represented regions that are hypothesized to be 
responsible for molecular interactions between the two domains (Williams and Martinis 2006) 
(Figure V.1).  However, the presence of these mutations did not enhance co-
immunoprecipitation detection of protein-protein interaction between the two domains when 
used in either purified or lysate form.  
 
Figure V.3 Immunoprecipitation assays with ΔCP1-Myc and CP1-HA.  Western blot showing 
results of co-immunoprecipitation pull-down of CP1-HA and ΔCP1-Myc in lysate form with 
antibody specific for the myc-tag.  The protein ladder was obtained from Invitrogen Corporation 
(Carlsbad, CA).   
CP1 Domain 
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V.3.2 Use of smFRET to Study Intramolecular Interactions of E. coli LeuRS during 
Translocation  
 
Translocation is the movement of the 3’ end of tRNA from the main body to the CP1 
domain of LeuRS.  I hypothesized that in order for translocation to occur, the canonical core 
and CP1 domain interact with each other to facilitate the transfer of the 3’ end of tRNA from 
one domain to another.  I used smFRET to probe for interactions of the aminoacylation core of 
LeuRS with its CP1 domain during translocation.   
In short, FRET is a measure of the energy transfer between a donor and acceptor dye. 
Bulk FRET is a useful technique to examine coordinated motions in an enzyme, however, the 
molecular properties of the enzyme are complex and sometimes it is not possible to detect 
uncoordinated intermediate pathways via bulk FRET.  Hence, a useful property of smFRET 
over bulk FRET is the detection of exact non-synchronized movements at specific regions of a 
protein that are potentially difficult to detect in bulk measurements (Lipman et al. 2003).   
I carried out smFRET experiments with an E. coli LeuRS labeled on Cys 317 (mutated 
from Glu 317), which is on the surface of the CP1 domain (Figure V.4), and E. coli tRNALeu 
with a dye in the anticodon stem.  The efficiency of energy transfer, E, is represented by the 
equation: 
E = (1 + (R/R0)6)-1                                                                                                                     [V.5] 
where R is the inter-dye distance, and R0 is the Förster radius at which E = 0.5 
Since the Förster distance for FRET is 50 Å and the distance between the synthetic active site 
and editing pocket is approximately 30 Å, the FRET dye pairs were places as far apart from 
each other to ensure the highest dynamic range for energy transfer to occur between both dyes.  
Given that the donor dye appended in the tRNA anticodon loop would bind in the canonical 
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core, I reasoned that the acceptor dye should be place as far back in the CP1 domain as possible.  
Thus, I chose  to label Glu 317 located at the back of the CP1 domain (Figure V.4).     
 
Figure V.4 Position of cy5 dye on LeuRS.  The crystal structure of T. thermophilus showing 
residue Glu 317 in blue space-filling form on the CP1 domain.  The Glu 317 was substituted 
with a cysteine and a cy5 dye was conjugated to the protein via that cysteine. PDB entry: 2BTE. 
(Tukalo et al. 2005).  
 
In order to identify the best possible method of labeling protein with a cyanine-based 
dye, I attempted to label LeuRS via various methods, including the use of an orthogonal system     
(Wang et al. 2006) as well as via a cysteine using maleimide chemistry (Mujumdar et al. 1993).  
The orthogonal method allowed us to insert an unnatural amino acid at a stop codon, which 
could then be conjugated to a dye.  The LeuRS was fluorescently labeled (Wang et al. 2003; 
Ryu and Schultz 2006) by incorporating p-acetyl-L-phenylalanine at Glu 317 of E. coli LeuRS.  
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The unique presence of a keto group in p-acetyl-L-phenylalanine facilitated the conjugation of a 
hydrazine-based cyanine dye to LeuRS.  We were successful in expressing LeuRS with               
p-acetyl-L-phenylalanine, but at insufficiently high levels for us to label it efficiently.  
Insufficient amounts at less than 20 µM of protein in 50 µL volume were obtained.  In addition, 
LeuRS with the p-acetyl-L-phenylalanine charged E. coli tRNALeu poorly (Figure V.5).   
 
 
Figure V.5 Expression of LeuRS with p-acetyl-L-phenylalanine inserted at stop codon and 
aminoacylation with modified enzyme.  On the left, aminoacylation reactions containing 4 µM 
tRNA, 4 mM ATP, 20 µM leucine or p-acetyl-L-phenylalanine, and 100 nM enzyme.  The 10% 
SDS-PAGE gel of the elutions of LeuRS containing p-acetyl-L-phenylalanine is shown on the 
right.  The protein of interest is boxed in red and E1 represents fraction 1 from the elutions; E2, 
fraction 2 from the elutions, and so forth.  
 
 
 
In order to boost the labeling efficiency of protein, I then turned to labeling a partial 
cysteine knockout protein in which Cys 37, Cys 128, Cys 505, and Cys 565 had been mutated to 
valine, serine, serine, and threonine respectively.  These cysteines were chosen based on the 
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analysis of the T. thermophilus crystal structure (PDB: 2BTE) with Visual Molecular Dynamics 
(VMD).  These four cysteines were less than 3.5 Å from the surface, and were predicted to be 
accessible for labeling.  The Glu 317 residue in the CP1 domain was mutated to a cysteine that 
was subsequently labeled with cy5 dye as described in the materials and methods section of this 
chapter.  This method of labeling proved to be more successful as I was able to express 
approximately 130 µM of protein in a total volume of 100 µL.  The labeling efficiency was 
calculated to be about 70%.  Photobleaching analysis was carried out with the labeled LeuRS by 
subjecting the labeled species to continuous laser excitation.  Approximately 50% of the LeuRS 
had just one photobleaching step, indicating that it was exactly labeled with one dye.  I then 
carried out smFRET experiments with this labeled LeuRS. 
The labeling of tRNA was initially carried out by the splint ligation of a tRNA 
comprising the modified nucleotide 5-C6-Amino-2’-deoxythymidine on which a NHS-cy3 
could be conjugated.  The first RNA fragment consisted of a chemically synthesized quarter 
length fragment of tRNA and harbored the modified nucleotide.  The second fragment was a 
transcribed piece of tRNA that was ¾ of the full length E. coli tRNALeu.  A DNA splint that was 
15 nucleotides long was used to hold these two fragments together.  The two RNA pieces were 
ligated together using T4 RNA ligase as described in the materials and methods section of this 
chapter.  Unfortunately, this method was very inefficient and less than 20 µM of ligated full 
length tRNA in a 50 µL volume was obtained.  The concentration of the modified full length 
tRNA was too low to be labeled.  Eventually, labeled tRNA was obtained commercially from 
ChemGenes (Wilmington, MA) and this synthesized tRNA had a cy3 dye inserted between 
guanosines 28 and 29 in the anticodon stem (Figure V.6).  
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Figure V.6 Schematic of tRNA labeled with cy3.  Labeled tRNA was chemically synthesized 
with a cy3 dye inserted between guanosines 28 and 29 in the anticodon stem boxed in red.  The 
structure in the red box on the right shows the detailed structure of the dye between guanosine 
28 and 29.  
 
 I carried out smFRET experiments with cy3 labeled tRNA as well as cy5 labeled LeuRS 
using Dr. Taekjip Ha’s TIR microscope at the University of Illinois at Urbana-Champaign.  The 
protein was efficiently immobilized on a quartz slide with approximately 500 fluorescently 
labeled single molecules conjugated to the slide using 20 nM histidine antibody specific for the 
his-tag on the protein (Figure V.7).  Various concentrations of labeled LeuRS ranging from 2 nM 
to 20 nM and labeled tRNA ranging from 2 nM to 15 nM were tested.  Finally, a concentration 
of 10 nM LeuRS and 4 nM tRNA was found to be optimal and used for all experiments. 
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Figure V.7 Surface immobilization of histidine-tagged LeuRS on quartz slide.  A. The histidine 
antibody is efficient in immobilizing labeled mutant his-tagged LeuRS (with 4 surface cysteines 
knocked out) on the surface of the slide.  B. Picture of slide as seen from the TIR microscope.  
Each blue dot represents a single fluorescently labeled single molecule.  Bars on top describe 
conjugation of LeuRS to the slide.       
 
Control experiments were conducted with AN2690 to trap cy3-tRNA on cy5-LeuRS 
(Rock et al. 2007).  As discussed previously in Chapter I.7, the boron containing compound 
AN2690 traps tRNA in the CP1 domain of LeuRS by forming an oxaborole adduct between the 
cis diols of the ribose (Rock et al. 2007).  When this occurs, the donor dye on the tRNA and the 
acceptor dye on the LeuRS CP1 domain are close enough in proximity for FRET to occur, and I 
hypothesized there should be an instance of medium FRET.  When the AN2690 comes off the 
complex, then tRNA will subsequently dissociate from the LeuRS and acceptor fluorescence 
will drop since the donor as well as acceptor dyes will be far apart.  I incubated 10 mM of 
AN2690, 4 nM cy5-tRNA and 10 nM of cy3-LeuRS at 37 °C for 1 h.  This complex was 
immobilized on the slide and a fairly strong acceptor signal was observed, indicative of energy 
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transfer between the donor and acceptor (Figure V.8).  This suggested that both the LeuRS and 
tRNA were successfully labeled with fluorescent dye and that fluorescence from the donor dye 
on the tRNA was transferred to the acceptor dye on the LeuRS.    
 
 
Figure V.8 The LeuRS-tRNA complex held together by AN2690. Here, smFRET experiments 
were carried out with 10 nM LeuRS, 4 nM tRNA and 10 mM AN2690.  The red line represents 
acceptor intensity and the green line donor intensity.  When the LeuRS and tRNA form a 
complex, acceptor fluorescence (red) is high but when the complex dissociates, acceptor 
fluorescence decreases.  
 
Comparison of crystal structures of LeuRS suggests that the CP1 domain rotates during 
aminoacylation (Tukalo et al. 2005).  I hypothesized that the CP1 domain moves towards the 
canonical core in order to facilitate the transfer of tRNA.  A series of smFRET experiments 
were carried out with either labeled wild-type or T252A LeuRS in the presence of tRNA, ATP 
and either leucine or isoleucine to further elucidate the interaction of the CP1 domain with the 
canonical core during the translocation of tRNA.  I first attempted to observe smFRET with cy5 
labeled wild-type LeuRS and cy3-tRNA in the presence of ATP and leucine.  I hypothesized 
that an instance of high FRET would be observed when the CP1 domain swings toward the 
canonical core in order to facilitate the transfer of the 3’ end of tRNA moving from the 
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canonical core to the CP1 domain.  However, very rare instances of smFRET was observed, 
with only approximately 1 in 600 observed single molecules displaying high acceptor 
fluorescence.  I attributed this to the high kcat of 10 s-1 for the aminoacylation reaction, thus 
resulting in the inability to capture the transient nature of translocation.  I then repeated the 
same experiment, but this time with cy5 labeled wild-type LeuRS and cy3-tRNA in the 
presence of ATP and isoleucine.  I reasoned that mischarging with isoleucine would slow down 
the aminoacylation reaction and there would be a higher possibility of capturing the transient 
conformational change of the LeuRS during translocation.  Unfortunately, this proved to be 
unsuccessful too and very rare instances of high acceptor fluorescence was observed.   
 Finally, I decided to insert the T252A mutation into the labeled wild-type LeuRS.  The 
threonine has been shown to function as a specificity determinant and causes LeuRS to 
mistakenly cleave correctly charged tRNA when this threonine is mutated to an alanine 
(Mursinna et al. 2001).  I hypothesized that the T252A mutant would result in a futile cycle of 
aminoacylation, whereby charged tRNA is constantly translocated to the CP1 domain for 
hydrolysis, thus availing uncharged tRNA for subsequent rounds of charging.  I reasoned that 
this would increase the possibility of capturing the translocation event via smFRET.  This also 
did not increase the observed occurrence of high FRET as compared to conditions tried 
previously with wild-type labeled LeuRS in the presence of leucine.  Overall, the acceptor 
signal I obtained from the various smFRET experiments was not significantly higher than the 
noise reading, hence too low for further data processing (Figure V.9).  In order to ensure the 
success of future smFRET experiments, further optimization is needed to obtain a stronger 
acceptor signal.  Strategies to label the dye at different locations on the protein using improved 
labeling techniques can potentially increase the acceptor fluorescence signal.   
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Figure V.9 Graph of fluorescence intensities with labeled LeuRS and tRNA. Here, smFRET 
experiments were carried out with 10 nM LeuRS, 4 nM tRNA and 1 µM ATP.  The red line 
represents acceptor intensity and the green line donor intensity.  When the LeuRS and tRNA are 
in complex, acceptor fluorescence is high but when the complex dissociates, acceptor 
fluorescence decreases.  The black line represents total fluorescence. 
 
V.4.  Discussion 
 The aminoacylation and editing active site of LeuRS are separated by about 30 Å   
(Tukalo et al. 2005) requiring the 3’ end of tRNA to move a significant distance in order for 
editing to occur.  I hypothesized that during this process, the canonical core and the CP1 domain 
are frequently interacting with each other at the molecular level in order to facilitate the transfer 
of tRNA.  However, the translocation of tRNA is very transient and difficult to study via 
structural and biochemical analysis.  Herein, I employed biophysical methods such as 
immunoprecipitation assays and smFRET techniques to elucidate the molecular crosstalk 
between the aminoacylation core and CP1 domain that facilitate the transfer of tRNA.   
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It was previously shown that two regions encompassing Lys 186 on the canonical core 
and Ala 293 on the CP1 domain in E. coli LeuRS, could stimulate pre-transfer editing via an 
unknown mechanism (Williams and Martinis 2006).  This was further supported by data 
indicating that Lys 186 acts as a molecular hinge in IleRS to enable editing (Bishop et al. 2003).  
Immunoprecipitation pull-down assays were conducted to test if isolated constructs of the CP1 
and canonical core could interact with each other.  Due to potentially weak and transient 
interactions of the main body with the CP1 domain, I was unable to reproducibly show that 
these two domains were interacting.   Interestingly, using the cell lysates of proteins for pull-
down assays enhanced interaction between the separate domains, leading us to believe that an 
unknown component of the lysate was essential for inter-domain interaction to occur.  In 
addition, K186E and A293D mutations were made in each of these constructs in order to 
promote interaction between both domains via the formation of salt bridges                  
(Williams and Martinis 2006).  However, this proved unsuccessful, again possibly due to weak 
and fleeting interactions between both domains.  
 Finally, smFRET techniques were employed to dynamically study the transient 
interactions between the main body and CP1 domain of E. coli LeuRS during the translocation 
of tRNA.  These experiments were designed based on our hypothesis that the CP1 domain 
would swing towards the canonical core in order to facilitate the transfer of tRNA.  A cy3 dye 
was inserted in the anticodon stem of tRNA while a cy5 dye was added at Cys 317 (previously       
Glu 317) of the E. coli LeuRS CP1 domain.  During this event, I hypothesized there would be 
an occurrence of high FRET due to the close proximity of the donor dye on the tRNA anticodon 
stem and the acceptor dye on the CP1 domain.  This approach also proved difficult because of 
the transient nature of translocation due to the high kcat of 10 s-1 for aminoacylation.  The high 
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KD of 0.3 µM for tRNA binding to LeuRS also increased the difficulty of this experiment as 
only nanomolar concentrations of labeled LeuRS and tRNA could be used for smFRET 
experiments.  In order to overcome the problem of the high kcat of aminoacylation, an attempt 
was made to create a futile charging event, resulting in a continuous translocation cycle of 
tRNA from the aminoacylation core to the editing domain.  This was carried out using the 
T252A LeuRS mutant, which hydrolytically cleaves correctly charged tRNA in the editing 
pocket, before releasing free tRNA to be charged again (Mursinna et al. 2001).  In addition to 
this, we explored the possibility of lowering the kcat of aminoacylation by substituting ATP in 
our smFRET experiments with ATPcPP, which is a non-hydrolysable ATP molecule with a 
carbon instead of oxygen linker between the α and β phosphate moieties.  Finally, I attempted 
to carry out mischarging of tRNA with isoleucine in order to slow down aminoacylation enough 
to capture the translocation event with smFRET.  All these optimized conditions failed to 
produce strong smFRET traces as acceptor fluorescence was not significantly higher than the 
background signal.  On hindsight, one possibility to improve the acceptor signal in our smFRET 
experiments is to re-label the protein, perhaps at a different location.  I can move the acceptor 
dye on the CP1 domain to the LSD (leucine specific domain), which has been shown by 
crystallographic structural studies to undergo larger movements relative to the CP1 domain 
during the aminoacylation process (Personal communication with Dr. Andrés Palencia).   
  In our current method of cysteine-maleimide labeling (Mujumdar et al. 1993), the 
protein still has to retain cysteines associated with the zinc binding domain in order for LeuRS 
to maintain activity.  This has resulted in multiple labels being conjugated to a proportion of 
proteins due to the presence of more than one cysteine.  With a more efficient labeling protocol 
in place, a more accurate and robust signal will be obtained from smFRET experiments.  One 
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strategy of re-labeling the protein is to use recently developed snap-tag technology that can 
specifically label proteins with fluorophores (Keppler et al. 2003; Keppler et al. 2004).  A     
snap-tag is two-thirds the size of a green fluorescent protein (GFP) molecule and originates 
from the O6-guanine nucleotide alkyltransferase that covalently reacts with any fluorophore 
carried on the benzyl-group of benzyl-guanines.  This snap-tag can be inserted at the backside 
of the CP1 domain in the vicinity of Glu 317.  A second alternative for labeling a protein is via 
a lanthanide tag, which is a short peptide sequence consisting of 15-20 amino acids that can 
bind Tb(III) which has luminescent properties (Sculimbrene and Imperiali 2006).  This 
approach will circumvent the problem of existing cysteines that are essential for the overall 
activity of the protein.  Finally, the protein can be labeled via an orthogonal system developed 
by Peter Schultz’s lab.  This will allow for the insertion of a fluorescent amino acid such as                       
L-(7hydroxycoumarin-4-yl)ethylglycine in the protein at an amber stop codon TAG             
(Wang et al. 2006).  This is a more efficient orthogonal insertion method than the one I 
attempted before as it avoids the need to label an amino acid with dye as it already has 
fluorescent properties.       
Another likelihood for the lack of success with smFRET is due to the protein losing its 
rotational flexibility while anchored to the quartz slide via its histidine tag.  In order to 
overcome this, the LeuRS can be immobilized on nanodiscs, which are nano–sized 
phospholipids bilayers (Bayburt and Sligar 2009).  Some cyanobacterial class I aaRSs have 
been found to associate with the cell membrane via a cyanobacterial aaRS appended domain 
(CAAD) (Luque et al. 2008).  The CAAD contains transmembrane helices that mediate its 
association with the plasma membrane (Luque et al. 2008).  It is possible that cloning a CAAD 
domain into E. coli LeuRS will first facilitate its localization to the phosphobilipids on the 
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nanodisc.  The approach will enable the LeuRS to be tethered to a phosphobilipid layer, 
allowing it to remain in its natural conformation, hence retaining its rotational flexibility. 
There is strong evidence for the interaction of the LeuRS canonical core and CP1 
domain in order to facilitate translocation, which is important for the maintenance of fidelity 
and viability (Tukalo et al. 2005; Williams and Martinis 2006; Hellmann and Martinis 2009; 
Mascarenhas and Martinis 2009).  I have conducted immunoprecipitation pull-down assays as 
well as smFRET experiments to study transient interdomain interactions during translocation, 
but was unable to clearly elucidate this process.  Further development of the smFRET assay via 
techniques discussed above is needed to fully understand this transient event.  
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88 
 
Chapter VI. Human Cytoplasmic LeuRS Involvement in Cell Signaling 
 
VI.1. Introduction 
 
 The aaRSs are a versatile group of enzymes that are involved in aminoacylation as well 
as a host of signaling activities (Park et al. 2005).  Aminoacylation itself is a two-part reaction 
mechanism that requires the aaRS to recognize nucleotide-based structures such as tRNA, as 
well as other small molecules such as amino acids and ATP (Mascarenhas et al. 2008).  Thus, 
the aaRSs have evolved to interact with a diverse set of molecules allowing them great 
functional versatility.  Sometimes, aaRSs even generate small molecules that go on to be 
involved in signaling activity.  For example, the GlyRS, LysRS, and TrpRS are able to 
synthesize diadenosine polyphosphates (ApnA), which are involved in a host of signaling 
functions (Edgecombe et al. 1997; Nishimura et al. 1997).  
 As discussed in the previous chapters, aaRSs from higher eukaryotes such as humans 
form a macromolecular complex in the cell.  It has been suggested that the aaRSs form a 
macromolecular complex in order to channel charged tRNA from the complex to the ribosome 
for translation to occur (Kyriacou and Deutscher 2008).  Furthermore, the aaRS macromolecular 
complex is proposed to act as a depot for additional regulatory factors that the aaRSs may need 
to carry out alternate functions within the cell (Ray et al. 2007).  Interestingly, many of the 
human aaRSs also have additional appended domains on them that can facilitate their 
interactions with other regulatory factors (Jia et al. 2008).  Nevertheless, the aaRS can still be 
found in various subcellular locations either in its free form or in complex with other aaRSs, 
depending on the function it has to carry out (Wakasugi and Schimmel 1999; Park et al. 2005). 
Considering the expanded functionality of the aaRSs especially in terms of cell signaling        
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(Park et al. 2005), it is not surprising that they have been linked to many diseases                   
(Park et al. 2008).    
 It has been shown that leucine is a critical factor for the activation of the mammalian 
target of rapamycin (mTOR) pathway (Lynch 2001).  The mTOR pathway serves as a central 
regulator of cell metabolism, proliferation, growth, and ultimately survival by integrating both 
extracellular and intracellular signals (Laplante and Sabatini 2009).  Although several factors 
mediate the leucine-induced mTOR activation (Bolster et al. 2004), they do not function as 
direct leucine sensors in the cell to monitor levels of free leucine available.  Based on this, it is 
hypothesized that human cytoplasmic LeuRS functions as a leucine sensor in the cell to control 
mTOR activation (Personal communication with Dr Jung Ming Han, Seoul National 
University).  Specifically, we hypothesized that hscLeuRS mediates mTOR directed 
translational control via hscLeuRS’s non-catalytic activity.  In collaboration with Dr. Sung 
Hoon Kim’s lab at Seoul National University, mutations were made in the hscLeuRS to knock 
out its aminoacylation activity.  In particular, we wanted to create mutants that would not bind 
and activate leucine efficiently, resulting in a lack of aminoacylation activity.  Secondly, it has 
been shown previously that the E. coli LysRS generates Ap4A during aminoacylation        
(Brevet et al. 1982), which could then go on to perform a host of signaling activities              
(Lee et al. 2004).  Based on this prior information, we conducted experiments to confirm that 
hscLeuRS does not operate similarly via a mechanism that generates Ap4A, that might then go 
on to affect mTOR signaling in the cell.  
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VI.2. Experimental Procedures 
 
VI.2.1. Mutagenesis 
 
A series of mutations were made within the editing pocket of hscLeuRS in order to 
severely disrupt leucine binding and activation.  Site directed mutagenesis was performed via 
PCR using the template plasmid pHSLARS1 that encoded the wild-type hscLeuRS gene. The 
plasmid pHSLARS1 was a gift from Weimin Mao and MRK Alley (Anacor Pharmaceuticals; 
Palo Alto, CA).  The F50A hscLeuRS mutant (pJPF50A) was generated using primers F50A-
Fwd (5'-GTA TTT TGT AAC CGC CCC ATA TCC ATA TAT G-3') and F50A-Rev (5'-CAT 
ATA TGG ATA TGG GGC GGT TAC AAA ATA C-3').  The Y52A hscLeuRS mutant 
(pJPY52A) was generated using primers Y52A-Fwd (5'-GTA ACC TTC CCA GCT CCA TAT 
ATG AAT G-3') and Y52A-Rev (5'-CAT TCA TAT ATG GAG CTG GGA AGG TTA C-3').  
The F50P hscLeuRS mutant (pJPF50P) was generated using primers F50P-Fwd (5'- GGG CAA 
GTA TTT TGT AAC CCC ACC ATA TCC ATA -3') and F50P-Rev (5'- TAT GGA TAT GGT 
GGG GTT ACA AAA TAC TTG CCC-3').  The F50H hscLeuRS mutant (pJPF50H) was 
generated using primers F50H-Fwd (5'-GGG CAA GTA TTT TGT AAC CCA CCC ATA TCC 
ATA TAT G-3') and F50H-Rev (5'-CAT ATA TGG ATA TGG GTG GGT TAC AAA ATA 
CTT GCC C-3').  The F50Y hscLeuRS mutant (pJPF50Y) was generated using primers F50Y-
Fwd (5'-GGG CAA GTA TTT TGT AAC CTA CCC ATA TCC ATA TAT G-3') and F50Y-
Rev (5'-CAT ATA TGG ATA TGG GTA GGT TAC AAA ATA CTT GCC C-3').  The F50W 
hscLeuRS mutant (pJPF50W) was generated using primers F50W-Fwd (5'-GGG CAA GTA 
TTT TGT AAC CTG GCC ATA TCC ATA TAT G-3') and F50W-Rev (5'-CAT ATA TGG 
ATA TGG CCA GGT TAC AAA ATA CTT GCC C-3').  Finally, the F50AY52A hscLeuRS 
mutant (pJPF50AY52A) was generated using primers F50AY52A-Fwd (5'-TTT GTA ACC 
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GCC CCA GCT CCA TAT ATG-3') and F50AY52A-Rev (5'-CAT ATA TGG AGC TGG GGC 
GGT TAC AAA-3').  Each 50 µL PCR mixture contained 50 ng of DNA template, 100 ng each 
of forward and reverse primer, 200 µM dNTPs, and 2.5 units of Pfu DNA polymerase in 
commercial buffer.  Each PCR reaction was carried out using conditions as described in Chapter 
II.  
VI.2.2. Detection of Ap4A Formation during Aminoacylation 
 
 The synthesis of Ap4A by E. coli LysRS was monitored at 37 °C in buffer containing     
20 mM Tris, pH 7.8, 150 mM KCl, 0.1 mM lysine, 5 mM MgCl2, 5 mM ATP, 1 mM DTT and 
100 µM ZnCl2.  Reactions were initiated with 1 µM human cytoplasmic LysRS (hscLysRS). 
(The purified enzyme was a gift from Dr. Karin Musier-Forsyth, Ohio State University, 
Columbus, OH).  A 20 µL aliquot was quenched into EDTA after 20 min (Brevet et al. 1982).  
The sample was then analyzed on a 6300 Series Ion Trap liquid chromatography/mass 
spectrometry (LC/MS) (Agilent Technologies, Foster City, CA).  The column of choice was a 
100 mm x 4.6 mm porous graphitic carbon (PGC) Thermo Hypercarb column                   
(Thermo Fischer, Waltham, MA).  The sample was separated on the PGC Hypercarb column 
using 50 mM ammonium acetate as the aqueous phase (A) and acetonitrile as the organic 
mobile phase (B) on the high performance liquid chromatographer (HPLC).  The sample was 
purified using a linear gradient that increased from 10 % to 70 % B in 12 min.  After HPLC 
purification, the sample was run through the 6300 Series Ion Trap equipped with an 
electrospray ionization (ESI) interface and was run in both the positive as well as negative 
mode.  The experiments were conducted using a full-scan mode with a mass range m/z of 0-900 
(Xing et al. 2004).    
 
 
92 
 
VI.3.  Results 
 
VI.3.1.  Rationale for Mutations 
 
 Mutations were made in hscLeuRS with the goal of abolishing leucine binding and 
activation activity.  We targeted the aminoacylation core in hscLeuRS, making mutants F50A, 
Y52A, F50P, F50H, F50Y, F50W, and F50AY52A.  These residues were chosen because of 
their close proximity to the HMGH peptide in the enzyme, which plays an important role in 
amino acid activation (Figure VI.1) (Webster et al. 1984).   
 
 
Figure VI.1 Crystal structure of the aminoacylation pocket of Pyrococcus horikoshii                  
(P. horikoshii) LeuRS.  The aminoacylation pocket of P. horikoshii is shaded in blue (PDB: 
1WZ2).  Highlighted in red are residues Val 40 and Phe 42 that are equivalent to Phe 50 and    
Tyr 52 in the hscLeuRS.  The HVGH peptide is shaded in yellow.  
 
I tested these mutants for aminoacylation activity as well as for amino acid activation activity.  
The mutants all had dramatically decreased aminoacylation activity as compared to the wild-
type hscLeuRS (Figure VI.2).  The kinetics for amino acid activation was determined by PPi 
exchange assays as described in the experimental procedures section in Chapter III (Table VI.1).  
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The mutants mostly had a lower kcat / KM value compared to wild-type due to an increased KM 
effect for amino acid activation.  Interestingly, the F50H mutant had a 15-fold increase in the 
kcat value for amino acid activation over wild-type hscLeuRS, possibly due to the positive 
charge on histidine, although the reason why is still largely unclear to us.     
 
 
Figure VI.2 Mutants of hscLeuRS have diminished aminoacylation activity. Leucylation 
activity was measured with 500 nM enzyme and 4 µM of transcribed E. coli tRNA. All enzyme 
reactions were carried out at 30 °C.  Wild type (WT) and mutant proteins are represented by the 
following symbols: WT, (   ); F50AY52A, (   ); Y52A, (   ); F50A, (   ); F50H, (   ); F50W, (   ); 
and F50Y, (   ).   
 
 
 
Table VI.1 Apparent kinetic parameters for leucine activation 
Enzyme Km (mM) kcat (s-1) kcat / KM (s-1mM-1) 
WT 0.024 ± 0.0089 2.09 ± 0.80 94.3 ± 23.4 
F50A 1.68 ± 0.47 0.017 ± 0.006 0.0056 ± 0.0002 
Y52A 1.03 ± 0.11 3.11 ± 0.44 3.41 ± 0.37 
F50AY52A 0.60 ± 0.09 0.30 ± 0.02 0.53 ± 0.05 
F50P 1.36 ± 0.34 2.04 ± 0.17 1.29 ± 0.11 
F50H 0.34 ± 0.01 32.3 ± 5.4 101.6 ± 16.9 
F50Y ‡ ‡ ‡ 
F50W 0.25 ± 0.04 0.55 ± 0.03 2.83 ± 0.05 
‡ Not determined because of low activity 
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VI.3.2.  The hscLeuRS Does Not Generate Ap4A 
 
 We carried out separate aminoacylation assays with hscLeuRS as well as hscLysRS to 
test for the generation of Ap4A.  The aminoacylation reactions were quenched as described in 
the experimental procedures section and quantitated based on LC/MS analysis.  The LC/MS 
spectrum from the hscLysRS aminoacylation reaction yielded a strong peak corresponding to 
Ap4A (Figure VI.3).  A much smaller peak was found at a 200 times lower intensity in the 
spectrum from the hscLeuRS sample (Figure VI.3), which we assumed to be due to background 
noise.  This indicated to us that the hscLeuRS, unlike the hscLysRS, could not generate Ap4A 
during aminoacylation.  
 
 
 
Figure VI.3 Mass spectrometric analysis reveals Ap4A formation by hscLysRS but not 
hscLeuRS.  A. The products from the aminoacylation reaction with LysRS run in the negative 
mode using ESI reveal a peak with m/z of 835.2 corresponding to Ap4A.  B. The products from 
the aminoacylation reaction with LeuRS run in the negative mode using ESI reveal a peak with 
m/z of 835.2 but at 200 times lower intensity than with hscLysRS.   
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VI.4.  Discussion 
 
 The goal of our collaboration with the Kim lab at Seoul National University was to 
generate mutants in the hscLeuRS that would lack aminoacylation activity due to a deficiency in 
leucine binding and activation.  I made seven mutants, mostly targeting a phenylalanine at 
position 50 in the aminoacylation pocket of hscLeuRS.  This particular phenylalanine was 
chosen because it is located close to the HMGH peptide in the enzyme, which plays an 
important role in amino acid activation (Figure VI.1) (Webster et al. 1984).  We reasoned that 
residues in proximity of the HMGH peptide would also be critical for amino acid activation to 
take place.  As hypothesized, these mutants were found to have very low aminoacylation 
activity.  They also had lowered kcat / KM values for leucine activation compared to the wild-type 
hscLeuRS.  The F50H was an exception in that it had similar kcat / KM values for leucine 
activation compared to wild-type due to reasons that remain unclear.  The Kim lab has 
continued to work with these mutants and will use them to further elucidate the role of 
hscLeuRS in mTOR signaling.  Finally, I determined that unlike hscLysRS, the hscLeuRS does 
not generate Ap4A during aminoacylation.  This confirmation was helpful as it helped us 
eliminate the possibility of hscLeuRS generated Ap4A signaling during the mTOR pathway.   
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Chapter VII. Protection of Charged tRNA by EF-Tu 
 
VII.1 Introduction 
 Accurate translation of the genetic code is reliant on the fidelity of aaRSs, as well as the 
precision of EF-Tu in delivering correctly charged tRNAs to the ribosome for participation in 
protein synthesis.  The EF-Tu has the responsibility of sampling a wide array of charged and 
mischarged tRNAs, before determining which aminoacylated-tRNAs to commit to ribosomal 
protein synthesis.  Mischarged tRNAs bind EF-Tu with a wide range of affinities, however, 
correctly charged tRNAs bind with similar affinities (Dale and Uhlenbeck 2005; Sanderson and 
Uhlenbeck 2007; Sanderson and Uhlenbeck 2007).  The overall binding affinity of EF-Tu for 
the aminoacylated tRNA is dependent on the sum of the individual thermodynamic 
contributions of the amino aid as well as the tRNA body (LaRiviere et al. 2001).  
Some organisms have adapted to accommodate mischarged tRNAs in cases that involve 
indirect aminoacylation pathways (Ibba and Söll 2000).  For example, many bacteria as well as 
archaea lack GlnRS and AsnRS, and generate a mischarged intermediate with GluRS and 
AspRS respectively that is later converted to correctly charged tRNA by transamidating 
enzymes (Wilcox and Nirenberg 1968; Ibba et al. 1997).  In order to prevent the misreading of 
specific codons under these conditions, EF-Tu has evolved to have low binding affinity for 
certain essential misacylated tRNAs such as Glu-tRNAGln, Asp-tRNAAsn, and Ser-tRNASec that 
are part of important pathways (Stanzel et al. 1994; Becker and Kern 1998; Ambrogelly et al. 
2007; Roy et al. 2007).  
Nevertheless, EF-Tu is not error-proof and on occasion allows translation of mischarged 
tRNAs, as seen from the incorporation of noncognate amino acids in vivo during translation 
(Apostol et al. 1997; Döring et al. 2001; Tang and Tirrell 2002; Roy et al. 2004;                  
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Wang et al. 2006).  For example, E. coli LeuRS has been shown to misactivate multiple amino 
acids such as norvaline in vivo such that it is incorporated throughout the proteome         
(Apostol et al. 1997).  Recent research has also shown that in order to increase the accuracy of 
protein synthesis, EF-Tu•GTP can dissociate from bound aminoacylated tRNA                   
(Ling et al. 2009).  If the tRNA is misaminoacylated, then this mischarged species can rebind to 
the aaRS and be resampled by its editing domain.  This provides an additional proofreading step 
that can result in an increase in quality control (Ling et al. 2009).  
It has been proposed that class I aaRSs are rate limited by product release and that       
EF-Tu forms a ternary complex with tRNA on the aaRS to facilitate its release                   
(Zhang et al. 2006).  In the context of E. coli LeuRS, I hypothesize that both charged and 
mischarged tRNALeu are translocated from the aminoacylation active site to the CP1 domain 
before product release to EF-Tu.  This is supported by data from our lab showing that a single 
T252A mutation in LeuRS uncouples specificity in the editing active site and allows hydrolysis 
of the correctly charged Leu-tRNALeu (Mursinna et al. 2001) (Figure VII.1).  I designed 
experiments with the aim of kinetically isolating the translocation of charged tRNA from the 
aminoacylation core to the editing active site. 
I conducted in vitro aminoacylation competition assays with the T252A E. coli mutant 
LeuRS and EF-Tu.  I hypothesized that the EF-Tu would compete with the editing site of 
T252A LeuRS to capture correctly charged Leu-tRNALeu before translocation to the editing site, 
where product is released.  As mentioned above, our lab has previously shown that a single 
T252A mutation in LeuRS uncouples specificity in the editing active site and allows hydrolysis 
of the correctly charged Leu-tRNALeu (Mursinna et al. 2001).  Hence, if the T252A LeuRS 
mutant releases Leu-tRNALeu before binding to the CP1 domain for proofreading, then I would 
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expect EF-Tu to slow the apparent rate of hydrolysis of Leu-tRNALeu to accumulate correctly 
charged Leu-tRNALeu. 
 
Figure VII.1 The Thr 252 residue in E. coli LeuRS.  On the left is the homology model of      
wild-type LeuRS with conserved threonine at position 252 highlighted in yellow.  On the right 
is a cartoon of the amino acid binding pocket within the editing active site, with Thr 252 
ensuring that only non-cognate amino acids can bind within the hydrolytic editing pocket.  
Substitution of threonine with an alanine (T252A) allows for cognate leucine to bind within the 
pocket.  This figure was partially adapted from reference (Mursinna and Martinis 2002).  
Reproduced with permission.  
 
VII.2. Experimental Procedures 
VII.2.1 Mutagenesis  
The T252A/H537A mutant was generated using PCR mutagenesis that is described in 
Chapter II from plasmid pMURe10_T252A encoding the E. coli T252A mutant             
(Mursinna et al. 2001).  The H537A mutant was inserted using primers H537A-Fwd (5'-CTA 
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ATA CGA CTC ACT ATA GTA GAC ACA AGG G-3') and H537A-Rev (5'-CCC TTG TGT 
CTA CTA TAG TGA GTC GTA TTA G-3') to give plasmid pJPT252A/H537A.  This mutant 
was then used in rescue assays with charged tRNA.  
VII.2.2 E. coli EF-Tu Expression, Activation and Use in Charged tRNA Rescue Assays 
 
 The E. coli EF-Tu was expressed from plasmid p20EfTu-25 (gift from Dr. Paul 
Schimmel, Scripps Research Institute, La Jolla, CA) using a protocol as described in Chapter II, 
except that the HA-I buffer was replaced with activation buffer S that contained 50 mM 
HEPES, pH 7.5, 10 mM MgCl2, 10 mM BME, 20 µM guanosine diphosphate (GDP), and 5% 
(v/v) glycerol.  The EF-Tu was activated immediately before use in assays by incubating 40 µM      
EF-Tu•GDP with 3 mM phosphoenolpyruvate, 30 µg/mL pyruvate kinase, 10 mM DTT, 20 µM 
guanosine triphosphate (GTP), 20 mM MgCl2, 50 mM HEPES, pH 7.0, and 0.05 M NH4Cl at    
37 °C for 3 h (Asahara and Uhlenbeck 2002).   
Aminoacylation assays were carried out as described in Chapter II.  The aminoacylation 
reactions each contained between 50 nM and 1 µM of E. coli LeuRS T252A/H537A mutant that 
had inactivated aminoacylation function as well as conferred editing for the correctly charged 
tRNALeu.  In addition, 50 nM to 1 µM of E. coli EF-Tu was added to rescue charged tRNA from 
the T252A/H537A editing pocket.  
VII.2.3 Pre-steady State Kinetics 
 
Pre-steady state kinetics were measured using a rapid RQF-2 KinTek chemical quench 
flow apparatus (Kin-Tek, Austin, TX).  Multiple turnover measurements were determined on a 
millisecond time scale.  Each reaction contained 5 µM of enzyme in the presence or absence of  
2 µM EF-Tu in buffer A containing 60 mM Tris, pH 7.5, 10 mM MgCl2, and 1 mM DTT in one 
syringe.  The other syringe contained 100 µM [14C]-leucine (318 mCi/mmol), 5 mM ATP, 
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0.08U of PPiase (Sigma, St. Louis, Mo), and 25 µM tRNALeu also in buffer A.  Aliquots of       
25 µL were dispensed by the apparatus and quenched with 82 µL of 3 M ammonium acetate, 
pH 5.0.  The collection tube of the apparatus held 10 µL of 10 % SDS to ensure the complete 
dissociation of enzyme from tRNA in order to quench the reaction.  The total reaction volume 
was spotted on a filter pad that had been presoaked with 5% TCA.  The pads were washed and 
quantitated as described in Chapter II.   
The data was analyzed using GraphPad Prism 4 and the equation VII.1:  
Rate of product formation/[active site]=A(1-ek1t)+C(k2t)+B                                  
where A is the amplitude of the exponential function, B is added to account for background 
radioactivity, C is the amplitude of the linear function, k is the observed rate, and t is time.  
VII.3. Results 
I hypothesized that EF-Tu competes with the editing site of LeuRS to capture correctly 
charged Leu-tRNALeu before translocation to the editing site.  In order to test this hypothesis, I 
chose to use the T252A LeuRS mutant as it was previously shown that T252A could bind 
correctly charged Leu-tRNALeu and hydrolyze it (Mursinna et al. 2001).  I conducted 
aminoacylation assays with T252A in the presence of EF-Tu, to assess if EF-Tu could             
out-compete the hydrolytic editing site and sequester correctly charged Leu-tRNALeu before it 
bound to the T252A LeuRS editing pocket.  Based on our experiments, the EF-Tu rescued      
Leu-tRNALeu accumulation but not to wild-type levels (Figure VII.2).  This indicated that the 
charged species was translocated to the editing domain before release to EF-Tu.  Thus, I 
propose that EF-Tu was primarily facilitating the release of Leu-tRNALeu from the editing active 
site.  
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Figure VII.2 Aminoacylation competition assays with EF-Tu. Aminoacylation and rescue 
activity was measured with 50 nM enzyme, 4 µM transcribed E. coli tRNA, and 1 µM EF-Tu.  
Wild-type and mutant proteins are represented by the following symbols: Wild type, (   ); wild 
type with EF-Tu, (   ); T252A, (   ); and T252A with EF-Tu, (   ).  Error bars are based on the 
results of three reactions each and indicated for each point. 
 
The use of the T252A/H537A mutant was chosen for this experiment because it does not 
aminoacylate tRNA, but binds correctly charged tRNA and hydrolyzes it within its editing site. 
The E. coli LeuRS was challenged with T252A/H537A LeuRS and EF-Tu, in order to test if     
EF-Tu was indeed facilitating the release of charged tRNA from LeuRS.  In our assays, the      
EF-Tu competes with the editing site of the T252A/H537A LeuRS mutant for the correctly 
charged Leu-tRNALeu.  If the T252A/H537A LeuRS mutant out-competes EF-Tu for               
Leu-tRNALeu, then the overall levels of Leu-tRNALeu would be expected to decrease.  I 
hypothesized that EF-Tu would sequester Leu-tRNALeu from wild-type LeuRS before 
T252A/H537A, thus preventing a drop in Leu-tRNALeu levels.  As predicted, my data showed 
that when wild-type LeuRS is challenged with T252A/H537A, EF-Tu rescues Leu-tRNALeu 
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from T252A/H537A to almost wild-type levels of Leu-tRNALeu, as in the absence of 
T252A/H537A LeuRS (Figure VII.3).  This suggests that charged Leu-tRNALeu is indeed 
translocated to the CP1 editing domain first, where EF-Tu then binds correctly charged          
Leu-tRNALeu.   
 
 
Figure VII.3 Aminoacylation competition assays with EF-Tu and T252A/H537A. 
Aminoacylation and rescue activity was measured with 50 nM enzyme and T252A/H537A,        
4 µM transcribed E. coli tRNA, and 1 µM EF-Tu.  Wild-type and mutant proteins are 
represented by the following symbols: Wild-type, (   ); T252A/H537A, (   ); wild-type with 
T252A/H537A,   (    ); and wild-type with T252A/H537A and 1 µM EF-Tu, (    ).   
 
It has been proposed that class I aaRSs are rate-limited by product release                
(Zhang et al. 2006).  Thus, under multiple turnover conditions with limiting enzyme, a kinetic 
burst would be unmasked, which is when aminoacyl transfer occurs at much higher rates than 
steady-state kinetics (kcat).  Rapid-quench experiments (Fersht and Kaethner 1976) can be used 
103 
 
to isolate kinetic steps that represent transiently formed charged tRNA under multiple turnover 
conditions. This will determine if EF-Tu competing with wild-type LeuRS changes the initial 
kinetic burst of the enzyme.  
Since rescue of aminoacylated product by EF-Tu was observed, I carried out rapid-
quench kinetic experiments under multiple turnover conditions to measure changes in the rate 
constants.  I reasoned that this would allow us to determine if LeuRS exhibits burst kinetics.  If 
this is true, then I would expect EF-Tu to reduce this burst with wild-type LeuRS since class I 
aaRSs are rate-limited by product release (Zhang et al. 2006).  Unfortunately, I did not observe 
a distinct display of burst kinetics during rapid-quench experiments with wild-type as well as 
T252A mutant.  Our attempts to further optimize experimental conditions were impeded by 
difficulty in expressing E. coli EF-Tu at high enough concentrations for rapid-quench 
experiments.  
VII.4. Discussion 
 Translation requires the specific attachment of amino acid to its cognate tRNA, before 
the charged tRNA is handed off to EF-Tu for delivery to the ribosome where protein synthesis 
occurs.  In E. coli LeuRS, charging of tRNA occurs in the canonical core domain while editing 
occurs in the CP1 domain 30 Å away (Tukalo et al. 2005).  I wondered if correctly charged 
tRNA was also translocated to the editing domain to be sampled, or if EF-Tu could directly pull 
the charged species off the canonical core domain.  Additionally, it was reported that charged 
tRNAs could be released from EF-Tu to be resampled by the aaRS (Ling et al. 2009).  Thus, it 
seemed plausible that the tRNA would skip sampling by its editing domain, since there was 
another chance whereby it could return from the EF-Tu and be edited.   
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I carried out a series of experiments with E. coli LeuRS to determine if correctly charged 
Leu-tRNALeu is translocated to the CP1 domain before being handed off to the EF-Tu.  The 
T252A mutant was chosen because of its unique ability to cleave correctly charged tRNA 
within its editing site (Mursinna et al. 2001).  When the T252A LeuRS mutant was challenged 
with an EF-Tu in an aminoacylation assay, there continued to be a low accumulation of Leu-
tRNALeu, suggesting that the EF-Tu was ineffective in sequestering correctly charged tRNA 
before transfer to the editing pocket for hydrolysis.  I also concluded that both correctly charged 
and mischarged tRNAs are translocated to the editing pocket to be sampled before release from 
the aaRS.  In order to further confirm this, a large excess of EF-Tu over tRNA should be used in 
future experiments in order to ensure that EF-Tu is not limiting in the reaction.  
It has been reported that EF-Tu binds to charged and mischarged tRNA species with 
different affinities (LaRiviere et al. 2001).  Thus, I speculated that EF-Tu would bind correctly 
charged tRNAs tightly, ensuring their quick release from the editing pocket.  Conversely, when 
mischarged tRNA is present, EF-Tu has a low affinity for it and the tRNA lingers within the 
CP1 domain for editing to occur.   Interestingly, previous investigations have showed that class 
I aaRSs are rate limited by product release (Zhang et al. 2006), suggesting that EF-Tu is needed 
to bind correctly charged tRNA at the CP1 domain to facilitate its release from the enzyme. 
I carried out competition assays with wild-type LeuRS and the T252A/H537A LeuRS 
mutant, in the absence and presence of EF-Tu.  The EF-Tu successfully competed with the 
T252A/H537A for the binding of charged tRNA and I noticed that EF-Tu competed with the 
T252A/H537A mutant for Leu-tRNALeu.  This suggested that EF-Tu tightly binds to               
Leu-tRNALeu to facilitate its release from LeuRS.  I then conducted a series of multiple turnover 
quench flow experiments in order to kinetically show EF-Tu facilitating the release of charged 
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tRNA as described in the results section.  I was however unsuccessful in this as I was unable to 
express EF-Tu to sufficiently high levels.  
Thus, a new method of expressing EF-Tu should be developed in order for subsequent 
experiments to be successful.  Since EF-Tu is made in large amounts within the cell       
(Jacobson and Rosenbusch 1976), it is possible to purify EF-Tu directly from E. coli cells via a 
matrix-bound GDP derivative (Jacobson and Rosenbusch 1977).  With greater amounts of 
purified EF-Tu, quench flow experiments can then be conducted with greater accuracy.  In 
addition, the ratio of EF-Tu to tRNA in rescue experiments described above should be 
optimized to ensure that tRNA is the limiting substrate.  The higher concentrations of purified 
EF-Tu will allow rescue experiments to be conducted with a large excess of EF-Tu over tRNA. 
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Chapter VIII. Conclusion 
 
 The aaRSs ensure fidelity during protein synthesis.  Each tRNA is accurately charged by 
its corresponding aaRS with cognate amino acid before being brought to the ribosome by EF-Tu 
for participation in protein synthesis (Hendrickson and Schimmel 2002;                    
Mascarenhas et al. 2008).  Based on its interaction with tRNA as well as ATP, the aaRSs have 
evolved to interact with a diverse set of molecules allowing them great functional flexibility.  
Many of these aaRSs have acquired alternate functions such as cell signaling activities on top of 
their involvement in protein synthesis (Martinis and Pang 2007).  
My thesis research consists of two distinct themes, the first being the characterization of 
hscLeuRS.  Considering the expanded functionality of the aaRSs especially in terms of cell 
signaling (Park et al. 2005), it is not surprising that they have been linked to many diseases   
(Park et al. 2008).  Hence, a deeper understanding of the hscLeuRS, in particular its editing 
function, is beneficial for advancements in pharmaceutical research that focus on aaRSs as 
targets for antibiotics (Rock et al. 2007).  The second theme of my thesis research centers on the 
interactions between the canonical core domain as well as the CP1 domain of E. coli LeuRS in 
order to facilitate the transfer of the 3’ end of tRNA into the editing pocket for it to be sampled.  
Previous research has shown that the CP1 domain rotates ~30° when tRNA is bound, relative to 
its apo state during translocation (Tukalo et al. 2005) and it has been hypothesized that this 
movement facilitates translocation of tRNA from the catalytic core domain to the CP1 domain 
for editing (Tukalo et al. 2005).   
I obtained the plasmid expressing hscLeuRS from Anacor Pharmaceuticals.  I focused 
mainly on characterizing the editing functions of hscLeuRS and mutations were made primarily 
in the editing pocket of the enzyme, including the Thr 298 and Asp 399 residues.  The 
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hscLeuRS is distinct from its bacterial counterparts as it contains four peripheral insertions not 
found in the bacterial enzymes (Seiradake et al. 2009).  These peripheral insertions have 
resulted in an architectural change in the CP1 domain although the integrity of the editing core 
is still maintained (Seiradake et al. 2009).  In my case, the mutation of Thr 298 to a bulky 
tyrosine did not have any effect on the editing function of hscLeuRS unlike in the E. coli 
enzyme, which knocked out post-transfer editing (Mursinna and Martinis 2002;                     
Pang and Martinis 2009).  I hypothesized that this tyrosine residue could flip into vacant space 
over the neighboring Val 479 to allow continued binding of the editing substrate.  Closure of 
one of the insertions (I4) in a cap-like function over the editing pocket might facilitate an 
induced fit that accommodates the bulky Tyr 298 mutation in the hscLeuRS editing pocket.   
I also demonstrated how a universally conserved aspartic acid in the CP1 domain was 
important for post-transfer editing as well as for interactions with the amino acid in the 
synthetic active site (Pang and Martinis 2009).  Substitution of this aspartic acid with an alanine 
led to a loss of post transfer editing as well as an increase in the KM for leucine activation                  
(Pang and Martinis 2009).  In addition, the overall aminoacylation activity was decreased for 
the D399A mutant compared to wild-type, consistent with the increase in KM for leucine 
activation with the D399A mutant.   
The D399A mutant lacked mischarging activity with transcribed E. coli tRNA even in 
the absence of post-transfer editing (Pang and Martinis 2009).  This led me to believe that in the 
absence of a post-transfer editing mechanism, a more ancient pre-transfer editing pathway is 
activated in order to maintain overall fidelity in aminoacylation.  Interestingly, the D399A 
mutant was sensitive to the presence of tRNA modifications as well as the origin of tRNA.  
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Unlike the weak mischarging observed with crude E. coli tRNA, no mischarging by D399A was 
observed with transcribed E. coli tRNA (Pang and Martinis 2009). 
The hscLeuRS is part of a macromolecular complex in the cell (Kaminska et al. 2009) 
although it is still unclear how the hscLeuRS with its CP1 domain fits into the macromolecular 
complex.  It is possible that the movement of the CP1 domain is impeded within the complex.  
Hence, a more redundant fidelity pathway is required to serve as the primary editing 
mechanism, as it does not require the translocation of mischarged tRNA from one domain to 
another.  The hscLeuRS CP1 domain in turn could be present to perform an alternate function 
or interact with other molecules that together with hscLeuRS serve another purpose in the cell.  
In view of the many other alternate functions that aaRSs can potentially serve, I 
collaborated with Dr. Sung Hoon Kim’s lab at Seoul National University.  The Kim lab is 
interested in studying hscLeuRS as a leucine sensor within the mTOR pathway.  I worked with 
them to generate mutations in the hscLeuRS that would lack aminoacylation activity.  I focused 
on making mutants that would be deficient in leucine binding and activation. I made mutations 
primarily at Phe 50 in the aminoacylation pocket of hscLeuRS.  These mutants were found to 
have very low aminoacylation activity and had lowered kcat / KM values for leucine activation 
compared to the wild-type hscLeuRS.  The F50H mutation was an exception and had similar   
kcat / KM values for leucine activation compared to wild-type due to reasons that are still unclear.  
The Kim lab has continued to work with these mutants and will use them to further elucidate the 
role of hscLeuRS in mTOR signaling.  
The second theme of my thesis was to study the interactions between the canonical core 
as well as the CP1 domain of LeuRS.  The E. coli LeuRS, unlike the hscLeuRS, is a monomer 
that relies on post-transfer editing in order to ensure fidelity.  In order for post-transfer editing 
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to occur, I hypothesized based on previous crystal structure data (Tukalo et al. 2005) that 
interaction between the canonical core and CP1 domain is essential.  Co-immunoprecipitation 
assays were used to capture this interaction.  However, due to potentially weak and transient 
interactions of the main body with the CP1 domain, I was unable to reproducibly show that 
these two domains were interacting.  Interestingly, cell lysates of proteins used for pull-down 
assays enhanced interaction between the separate domains, leading us to believe that an 
unknown component of the lysate was essential for inter-domain interaction to occur.  I initially 
hypothesized that the presence of EF-Tu and/or tRNA was important for the interactions of both 
domains, however, the addition of purified EF-Tu and tRNA to the individually purified ΔCP1 
as well as CP1 domain did not enhance interactions between the two sub-domains during pull-
down assays.  It is possible that other factors such as concentrations of substrates as well as 
environmental conditions similar to those in cell lysates play a part in enhancing interaction 
between the two domains.  
In collaboration with Dr. Taekjip Ha’s lab, smFRET experiments were conducted in 
order to dynamically study the transient interactions between the main body and CP1 domain of 
E. coli LeuRS during the translocation of tRNA.  This approach also proved challenging 
because of the transient nature of translocation due to the high kcat of 10 s-1 for aminoacylation.  
The high KD of 0.3 µM for tRNA binding to LeuRS also increased the difficulty of this 
experiment as only nanomolar concentrations of labeled LeuRS and tRNA could be used for 
smFRET experiments.  I was thus unable to observe strong smFRET signals from our 
experiments due to many technical challenges.  However, a more efficient re-labeling strategy is 
one possibility of improving the acceptor signal in our smFRET experiments.  With an 
efficiently working smFRET set-up, I will be able to dynamically observe the detailed 
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conformational changes that LeuRS undergoes in order to bring about the translocation of 
tRNA.  In fact, smFRET technology can even be harnessed to obtain in depth kinetic 
information of the transition steps between each conformational change of LeuRS during the 
translocation of tRNA.  This would ultimately deepen our understanding of the tRNA 
translocation process in LeuRS that is fundamental for accurate charging of tRNA to occur.   
Finally, I carried out a series of experiments with E. coli LeuRS to determine if the 
translocation of tRNA could be omitted and correctly charged Leu-tRNALeu handed off directly 
to the EF-Tu at the canonical core.  I found E. coli EF-Tu to be ineffective in sequestering 
correctly charged tRNA before transfer to the editing pocket for hydrolysis.  I also concluded 
that both correctly charged and mischarged tRNAs are translocated to the editing pocket to be 
sampled before release from the aaRS.   
The competition assays with wild-type LeuRS and the T252A/H537A LeuRS mutant, in 
the absence and presence of EF-Tu suggested that EF-Tu binds to Leu-tRNALeu tightly in order 
to facilitate its release from LeuRS.  The E. coli LeuRS is a class I enzyme that displays burst 
kinetics (Zhang et al. 2006).  Multiple turnover quench flow experiments to check for a release 
in burst kinetics with EF-Tu were unsuccessful as I was unable to express EF-Tu to sufficiently 
high levels.  
In summary, the interactions between the canonical core and editing domain of E. coli 
LeuRS are very transient and have been difficult to trap.  In order to maintain a high level of 
accuracy during charging, the enzyme resorts to a high catalytic turnover in order to ensure that 
the editing domain samples all the charged tRNA before being released to EF-Tu.  The 
hscLeuRS on the other hand carries out pre-transfer editing that does not require the 
translocation of tRNA from one domain to another.  It is possible that hscLeuRS has evolved to 
111 
 
depend on pre-transfer editing because the dynamics of the CP1 domain are impeded when it is 
in the macromolecular complex.  
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Appendix. Plasmid Constructions 
 
Plasmid Name Parent Plasmid Description 
pJPCP1HA pBETeCP1-2-35 E. coli CP1 (V216-A430) domain with HA tag 
pJPmbHA pMTV-ΔCP13a E. coli  ΔCP1 domain with myc tag 
pJPCP1myc pBETeCP1-2-35 E. coli CP1 (V216-A430) domain with myc tag 
pJPmbmyc pMTV-ΔCP13a E. coli  ΔCP1 domain with myc tag 
pJPT252A/H537A pMURe10_T252A E. coli T252A/H537A 
PJPmmK186E pJPmbmyc E. coli Main body with myc-tag and K186E mutation 
PJPCHA293D2 pJPmbHA E. coli CP1 with HA tag and A293D mutation 
pJPE317amber p15ec3 Amber stop codon replaces codon GAA (Glu 317) 
pJPN275amber p15ec3 Amber stop codon replaces codon AAT (Asn 275) 
pJPE367amber p15ec3 Amber stop codon replaces codon GAA (Glu 367) 
pJPE329amber p15ec3 Amber stop codon replaces codon GAA (Glu 329) 
pJPE317amberChis pJPE317amber Amber stop codon replaces codon GAA (Glu 317) with his-tag at C-terminus in pET21 
pJPN275amberChis pJPN275amber Amber stop codon replaces codon AAT (Asn 275) with his-tag at C-terminus in pET21 
pJPE367amberChis pJPE367amber Amber stop codon replaces codon GAA (Glu 367) with his-tag at C-terminus in pET21 
pJPE329amberChis pJPE329amber Amber stop codon replaces codon GAA (Glu 329) with his-tag at C-terminus in pET21 
pJPC37V p15ec3-1 C37V in E. coli LeuRS 
pJP2_cys pJPC37V C37V/C128S in E. coli LeuRS 
pJP3_cys pJP2_cys C37V/C128S/C505S in E. coli LeuRS 
pJP4cysko pJP3_cys C37V/C128S/C505S/C565T in E. coli LeuRS 
pJP4cysko317C pJP4cysko C37V/C128S/C505S/C565T/E317C in E. coli LeuRS 
pJP4cysko329C pJP4cysko C37V/C128S/C505S/C565T/E329C in E. coli LeuRS 
pJP4cysko275C pJP4cysko C37V/C128S/C505S/C565T/N275C in E. coli LeuRS 
pJPA109C pJPEFTu3cysko E. coli EF-Tu C82A/C138A/C256A/A109C 
pJPV171C pJPEFTu3cysko E. coli EF-Tu C82A/C138A/C256A/V171C 
pJP4cyskoT252A pJP4cysko C37V/C128S/C505S/C565T/E317C/T252A in E. coli LeuRS 
pJP5cysko317C pJP4cysko C37V/C128S/C505S/C565T/E317C/C179S in E. coli LeuRS 
pJP6cysko317C pJP5cysko317C C37V/C128S/C505S/C565T/E317C/C179S/C175GC176R in E. coli LeuRS 
pJP8cysko317C pJP6cysko317C C37V/C128S/C505S/C565T/E317C/C179S/C175GC176R/C285G in E. coli LeuRS 
pJP9cysko317C pJP8cysko317C C37V/C128S/C505S/C565T/E317C/C179S/C175GC176R/C285G/C769A in E. coli 
LeuRS 
pJPEFTuC82A p20EfTu-25 E. coli EF-Tu C82A 
pJPEFTu2_cys pJPEFTuC82A E. coli EF-Tu C82A/C138A 
pJPEFTu3cysko pJPEFTu2_cys E. coli EF-Tu C82A/C138A/C256A 
pJPtRNA3/4 ptDNAleu14 3/4 of tRNA (ptLeu14). 1/4 of tRNA deleted, starting from 5' end. 
GCCCGGAUGGUGGAAUCG deleted. E. coli tRNALeu 
pJPC2U ptDNAleu14 C2U mutation in E. coli UAA tRNALeu 
pJPC3U ptDNAleu14 C3U mutation in E. coli UAA tRNALeu 
pJPC4U ptDNAleu14 C4U mutation in E. coli UAA tRNALeu 
pJPC2UG71A pJPC2U C2U and G71A mutation in E. coli UAA tRNALeu 
pJPC3UG70A pJPC3U C3U and G70A mutation in E. coli UAA tRNALeu 
pJPC4UG69A pJPC4U C4U and G69A mutation in E. coli UAA tRNALeu 
pJPD399A pHSLARS1 HscD399A 
pJPT298A pHSLARS1 HscT298A 
pJPT298Y pHSLARS1 HscT298Y 
pHSLARS1 pHSLARS1 HscWT from Anacor Pharmaceuticals 
pJPDATY2 pJPD399A HscD399A/T298Y 
pJPTYTV pJPT298Y HscT293V/T298Y 
pJPDATV pJPD399A HscD399A/T293V 
pJPDATYTV pJPDATV HscD399A/T293V/T298Y 
pJPT298W pHSLARS1 HscT298W 
pJPF50A pHSLARS1 HscF50A 
pJPY52A pHSLARS1 HscY52A 
pJPY54A pHSLARS1 HscY54A 
pJPQ629A pHSLARS1 HscQ629A 
pJPF50AY52A pJPF50A HscF50A/Y52A 
pJPF50Y pHSLARS1 HscF50Y 
pJPF50P pHSLARS1 HscF50P 
pJPF50H pHSLARS1 HscF50H 
pJPF50W pHSLARS1 HscF50W 
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